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GENERAL INTRODUCTION 
The human' s efforts to improve the performance of athletes in sports through 
medication are as old as competitive sports themselves. The first report of "doping" in 
racing horses in England occurred at Worksop around 1666 (Tobin, 1981). "Doping", by 
its original definition in the race industry , is generally deemed to be the use of substances 
other than normal nutrients that could affect a racing animal's performance at the time of 
racing. With increasing knowledge of doping, the term "doping" is broadened now. The 
British authorities redrafted their definition of doping in the late 1970s. The new 
definition is described as "the detection in its tissues, body fluids or excreta of any 
quantity of any substance which is either a prohibited substance or a substance the origin 
of which cannot be traced to normal and ordinary feeding and which by its nature could 
affect the performance of the racing animal." By this definition a prohibited drug is a 
substance originating externally, whether or not it is endogenous to the animal, which can 
not be traced to normal and ordinary feeding and which can affect the performance of a 
animal (Tobin , 1981). 
Many different drugs are open to abuse by people and animals involved in sports 
now. Most of them are exogenous compounds, others are naturally occurring substances , 
so called endogenous materials. An endogenous material is an organic substance which is 
produced within a plant or an animal; an exogenous material is a substance which is not 
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synthesized in the body or can not obtained from ordinary food and which must therefore 
be obtained from an exogenous source. 
From the seventeenth century until the late of the nineteenth century , because of 
lacking efficient drug testing assays , the practice of doping in the horse-racing industry 
spread like wildfire throughout the world. Many trainers gave a variety of drugs to their 
horses to make them win or lose unfairly over the horses who were not given drugs. 
Doping and its prevention have been the main stimulus for studies of drug testing and 
drug metabolism in the horse. The other two species in which doping occurs to a 
significant extent are man and the dog . In the United States, the first serious effort at pre-
race testing took place in Maryland , where professor James Munch introduced a pre-race 
test in the 1930s (Tobin, 1981). Since then , testing of horse for drug presence by 
chemical analysis of bodily fluid s has been developed and introduced in the racing 
industry. 
Today, the analytical detection of prohibited drugs in racing animals has evolved 
to a high state of art with the development of more sophisticated instrumentation. There 
is a wide variety of drugs testing techniques that can be used to analyze and detect 
various drugs in biological fluids of racing animals. Collection of such fluids should not 
in general interfere with the animal , so that its racing performance might be affected. 
This limits the analyst to samples of urine, blood, saliva and sweat. 
Urine is the most commonly collected biological fluid sample in racing chemistry. 
Chemical analysis of urine samples usually requires the following general steps: sample 
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preparation; screening of sample for the suspected drug; and final confirmation and 
quantita.tion. 
A sample preparation procedure is usually to provide a relatively clean sample for 
analysis (thereby improving selectivity and precision) and to concentrate the sample 
(improving the sensitivity of analysis). Liquid-liquid extraction remains the most 
commonly used sample preparation technique in analytical chemistry. Besides liquid-
liquid extraction, solid phase extraction and other sample preparation techniques are also 
available. The commonly utilized screening techniques in drug testing include: (1) direct 
methods, such as gas chromatography (GC), high performance liquid chromatography 
(HPLC), gas chromatography and mass spectrometry (GC/ MS), high performance liquid 
chromatography and mass spectrometry (HPLC/MS); (2) indirect method, such as newly 
developed immunoassay techniques. 
As previously mentioned, the principal use of drugs in race-animals is to make 
them win (or lose) unfairly. Many racing organizations are concerned with the abuse of 
drugs to influence the racing performance of animals, and this is reflected in the nature of 
the compounds studied. There is a big difference between exogenous drug testing and 
endogenous drug testing. For exogenous compounds since the results of drug tests are 
normally reported as either positive or negative, presence of the drug in body fluids, once 
confirmed, will provide strong evidence for doping. However, fo r endogenous drugs, it is 
very difficult to determine if a positive result is due to administration of the drug or 
natural levels of the drug in the animal. 
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In order to differentiate between normal endogenous levels and dosed exogenous 
levels of the drug in biological samples, including urine, it is necessary to investigate and 
determine a population "normal" value for an endogenous substance which could not be 
traced to ordinary feeding. A population normal level for an endogenous material is a 
threshold level which can be obtained by analyzing a great variety of biological samples 
at normal physiological state without exogenous contamination of the substance. 
The primary purpose of this study was to investigate the threshold concentrations 
of two endogenous compounds, dimethyl sulfoxide (DMSO) and hydrocortisone, and their 
metabolites. The drug concentrations were determined by using the optimum analytical 
method of choice. The threshold values were evaluated to differentiate between normal 
concentrations and exogenous dosed concentrations of these two compounds in dog urine. 
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SECTION I. DIMETHYL SULFOXIDE 
6 
INTRODUCTION 
Dimethyl sulfoxide (DMSO) and its metabolite dimethyl sulfone (DMS02) are 
both naturally occurring compounds with potent anti-inflammatory and analgesic action in 
man and animal . In the racing community, however, DMSO/DMS02 might be used 
exogenously as stimulants to the central nervous system of racing animals (Tobin , 1982). 
In order to prevent the possible misuse of DMSO and DMS02, the chemist must 
differentiate between naturally occurring levels of DMSO and DMS02 and levels which 
arise due to exogenous administration of the compounds. Because of this, very sensitive 
and selective analytical methods are necessary to determine the naturally occurring level 
of these two endogenous compounds in the urine of greyhounds. 
By understanding the natural levels, the analyst can begin to explore analytical 
thresholds which can be used to scientifically distinguish between endogenous and 
exogenous levels of these two compounds in the racing animal. Few studies of threshold 
determination involving endogenous drugs of possible abuse have been reported. Law et 
al.(1991) investigated the threshold concentrations of DMSO and DMS02 that occur 
normally in horse urine and plasma. They concluded that DMSO occurs normally in 
horse urine and plasma and arises mainly (if not entirely) from the diet, particularly 
luceme hay. The proposed urinary DMSO threshold was 15 ug/ ml , the proposed plasma 
DMSO threshold was 1.0 ug/ ml. They indicated that DMS02 was also a normal 
constituent of equine urine and plasma. 
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The purpose of this study was to determine the threshold concentrations of DMSO 
and DMS02 and differentiate between normal concentrations and exogenous dosed 
concentrations in dog urine. 
The object of the first part of thi s work was to determine method characteristics 
such as analyte recovery, detection ranges , specificity, reliability, precision and accuracy 
for the analysis of DMSO and DMS02 in biological samples. The second objective of this 
work was the determination of endogenous values of DMSO and its metabolite DMS02 in 
greyhound urine using the optimum method of choice. 
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LITERATURE REVIEW 
General Characteristic and Pharmaceutical Effects 
General characteristic 
Dimethyl sulfoxide (DMSO) is a naturally-occurring organic compound within the 
food chain. All plant materials of marine origin contain trace quantities of DMSO 
(Herschler et al., 1982). At present, there are only limited reports of DMSO in nature. 
Traces of DMSO, or its metabolites, have been found in spearmint oil, nonfat milk, 
water, and in a variety of fruits , vegetables, grains and beverages (Pearson et al., 1981) . 
It also has been suggested that DMSO and its metabolites are normal constituents of urine 
and plasma of man , equine, bovine, canine, and other animals (Hucker et al., 1967; 
Gerhards and Gibian, 1967; Tiews et al., 1975; Law et al., 1991). DMS02 , also called 
methyl sulfonyl methane (MSM) or dimethyl sulfone, a stable metabolite of DMSO, may 
be necessary at low levels in mammals to maintain normal health , structure and function 
(Jacob, 1982) . The responses of DMSO and DMS02 level to equine diet were reported by 
Law et al., 1990. The results revealed that a high-lucerne-hay diet led to a significant 
increase in urinary DMSO, showing that the substance was mainly of dietary origin, 
rather than endogenous. DMS02 also increased appreciably on feeding lucerne hay, much 
more so than DMSO. The increase was too large to be due to the original DMS02 alone 
and most of it must have arisen metabolical ly. 
Chemically, DMSO is a dipolar, aprotic, hygroscopic solvent. The dipolar, 
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nucleophilic character of the molecule is due to the available free electron pairs at the S 
and 0 terminals. In most cases aprotic solvents like DMSO in various liquid media act 
neither as an acid nor a base. Pure DMSO is nearly odorless and has a slightly bitter 
taste. It is a clear , colorless to yellow liquid that freezes at 18.5 °c, and boils at 189 °c. 
Its molecular weight is 78.13. DMS02 's molecular weight is 94.33. Boiling point is 238 
°C (Ogden, 1967; Rammler and Zaffaroni, 1967; Kharasch and Thyagarajan., 1975; 
Brayton, 1986). 
DMSO was first prepared by the oxidation of dimethyl sulfide by Alexander 
Saytzeff in 1867. Commercially DMSO was produced by the Stepan chemical company in 
the 1950's (David, 1972). DMSO can act as both an oxidizing and a reducing agent. 
When acting as an oxidant, DMSO is reduced to dimethyl sulfide (DMS), and when 
acting as a reducing agent , DMSO is oxidized to dimethyl sulfone (DMSOi). At present, 
in the United States, DMSO is commercially produced from lignin, a byproduct of the 
paper-making industry. 
Pharmaceutical effects 
In the early 1960s, the scientific community began to show serious interest in the 
medical potential of DMSO. In the early 1970s, DMSO was approved by the FDA for 
veterinary use in musculoskeletal injuries in dogs and horses. In 1978, the FDA 
authorized the use of 50 % DMSO for the treatment of interstitial cystitis, a rare bladder 
disease, in humans (Brayton , 1986). Experimental studies in animals have shown that 
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dimethyl sulfoxide can produce a variety of biological effects. Properties that are 
considered to be particularly important to its pharmacological effects including: 
(1) Penetration In man and lower an imal, DMSO readily penetrates most tissue 
membranes and enhances penetration of other substances across biologic membranes. In 
man , radiolabeled DMSO can be detected in the blood within five minutes of cutaneous 
application, Within twenty minutes, DMSO can be found in all organs of the body. After 
one hour, radioactivity can be detected in bones and teeth (Kolb et al., 1967). 
DMSO most effectively penetrates skin in concentrations of 80- 100%. Its 
penetrating ability is believed to be due to its exchange and interchange for water in 
biological membranes, causing a reversible configurational change of the skin protein , 
and accounting for the rapid passage of DMSO through the skin (Jacob et al. , 1971 ) . 
DMSO also penetrates mucous membranes (blood-brain barriers , cell and 
organelle membranes (Kocsis et al. , 1968). DMSO can serve as a vehicle for many 
substances and faci litate their penetration across membranes, a property which may be 
used to the benefit of or abused to the detriment of the recipient. For instance, in rac ing 
animals, DMSO can be used to facilitate percutaneous transport of therapeutic or 
prohibited drugs into the body. DMSO carries substances rapidly and deeply into the 
horny layer of the skin (Sulzberger et al. , 1967). DMSO has been shown to be an 
effective diuretic due to an increase in the urinary excretion of sodium and potassium 
(Koller, 1976; Blythe et al. , 1986b). 
(2) Anti-inflammation DMSO apparently has significant anti-inflam mato ry 
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properties. The mechanisms involved here are complex. Some researchers indicated that 
the anti-inflammatory effect of DMSO may be due to its ability to scavenge 
inflammation-triggering free radicals and its ability to inhibit the neutrophil bactericidal 
activity (Jacob and Herschler, 1986). 
In racing animals, the most popular uses of DMSO are for treatment of arthritic, 
tissue injuries, musculoskeletal injuries, acute trauma, and many of the common injuries 
(Richardson., 1973; Averkin et al., 1975 ; Gorog and Kovacs, 1975; Koller, 1976; Wong 
and Reinertson, 1984). 
(3) Analgesic action One of the most prominent pharmacologic actions of 
DMSO is the reduction of pain. Numerous clinical studies have been reported about pain 
relief action of DMSO. DMSO was reported to produce analgesia both locally and 
systemically, suggesting that DMSO either has been carried by the circulation to the 
affected area to act locally, or has depressed the central nervous system pain centers--or 
both (Haigler and Spring, 1981). 
DMSO reversibly decreases the conduction velocity of nerves. One study, carried 
out by Sams (1967), showed that the conduction velocity of the isolated frog's sciatic 
nerve was decreased 40 % by immersion for several hours in 6% DMSO. This effect was 
totally reversed by washing the nerve in a buffer for one hour. DMSO injected 
subcutaneously (10% concentration) into cats produced a total loss of the central pain 
response. Two milliliters (50% DMSO) injected into the cerebrospinal fluid led to total 
anaesthesia of the animal for 30 minutes without apparent adverse reactions (Jacob and 
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Herschler , 1986). 
Analgesia by DMSO may be more comparable to narcotic analgesia than to local 
anesthesia by procaine derivative drugs. The "hot plate" and "tail flick" tests are standard 
tests of narcotic analgesia in rats. After studying the effect of DMSO in these tests, 
Haigler and Spring (1981) reported DMSO produces an analgesia effect comparable in 
magnitude to morphine, but it is longer lasting and is not reversible by administration of 
naloxone. They concluded that the mechanism of analgesic action of DMSO is apparently 
different from that of morphine because naloxone, a specific narcotic antagonist, does not 
block the analgesic effect of DMSO. This indicates that opiate receptors are not involved 
in DMSO-induced analgesia. One mechanism suggested is a chemical block of small 
nerve fibers (the C fibers on nonmyelinated nerve fibers). The block is reversible; the 
effect usually continues for four to six hours. Shealy studied peripheral small fiber after-
discharge in the cat. Concentrations of 5- 10% DMSO eliminated the activity of C fibers 
within one minute; activity of the fibers returned after the DMSO was washed away 
(Shealy, 1966; Jacob , 1982). 
(4) Other central nervous system effects Tranquilizing or sedating effects have 
been noticed after topical, oral, or parenteral administration of DMSO in several species, 
including man. Braude and Monroe (1967) gave intraperitoneal injections of 5 g/kg of 
DMSO to mice, and found a decrease in the spontaneous motor activity and an increase 
in the hexobarbital sleeping time. Other authors had similar discovery (Kocsis et al., 
1968; Kocsis et al., 1975). Intravenous DMSO reduced the dose of chloralose and 
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methohexital required to maintain anaesthesia in dogs (Peterson and Robertson, 1967). 
(5) Respiratory effect The primary respiratory effect reported is increased rate 
and/or depth when high doses of DMSO (5000 or 10000 mg/ kg in 25 % solution) are 
administered to lightly anesthetized dogs (Peterson and Robertson , 1967). Rowed and De 
La Torre (1973) also indicated that DMSO may act as a respiratory stimulant. Marin 
(1975) reported that DMSO therapy on chronic respiratory insufficiencies appears to be 
very effective. Klein et al. (1983) demonstrated some improvement in adult respiratory 
distress syndrome after DMSO administration. One possible conclusion is that DMSO 
may act as a respiratory stimulant. But pure DMSO (200 mg/kg) has been reported to 
cause respiratory depression and apnea (Di Stefano and Klahn , 1965). 
(6) Toxicity of DMSO DMSO's systemic tox icity is considered to be low . In 
dog , the single dose intravenous LD-50 was reported as 2.5 g/kg body weight (Rubin, 
1983) . Dermal and oral LD-50 for dog were greater than 11 g/kg and 10 g/kg 
respectively (Smith et al., 1967). The therapeutic intravenous dose is approximately 1.0 
g/kg in a 10-45 % solution, administrated slowly to humans (Waller et al ., 1983) , dogs 
(De La Torre et al., 1975; Rucker et a l., 1983) and horses (Mayhew and Mackay, 1982). 
Metaboli m and Elimination 
The major pathways of DMSO metabolism in man and animal are illustrated in 
Figure 1 (Rammler and Zaffaroni , 1967). Both DMS02 and dimethyl sulfide (DMS) have 
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Figure 1. The major path ways of DMSO metabolism (Rammler and Zaffaroni, 
1967) 
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been identified as metabolites of DMSO in man and animal (Gerhards and Gibian, 1967). 
Metabolism and urinary excretion of the parent drug are the major methods of 
elimination. 
It was suggested that DMS, which unlike DMS02 , can be reconverted to DMSO 
(Williams et al., 1966). Jacob et al.(1971) demonstrated that DMSO and DMS02 were 
present in all examined tissues of rats 2 hours after administration of DMS0-35S including 
both hard (i.e. lens and bone) and soft tissues, Hard tissues, i.e ., lens and bone, 
accumulated approximately one-sixth the radioactivity that most of the soft tissues 
accumulated in the same period of ti me. 
Unchanged DMSO is most prevalent in tissues, blood, feces and urine, with 
DMS02 also present, but in much smaller percentage. It has been estimated that dimethyl 
sulfide (DMS) accounts for less than 5 % of the administered dose in most species 
reported. Approximately 3-6% of the original dose of DMSO is reduced to DMS and 
exhaled. The distribution phase of DMSO is very rapid . Regardless of the route of 
administration of DMSO, a remarkable amount of radioactive DMSO is found in the 
plasma after only 30 minutes. Cutaneous application of DMSO results in lower plasma 
levels than when DMSO is administered intravenously . Maximal blood concentrations of 
DMSO applied cutaneously are reached in two hours. An oral dose of 1 g/ kg results in 
peak plasma level in 4-6 hours and is detectable for 400 hours. An intravenous 
administration at the same dosage achieves a higher plasma level and is more rapidly 
distributed to all tissues (Yellowlees et al ., 1980). One and one-half to two hours after 
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cutaneous administration of DMSO, the highest concentration is found in the kidneys, 
indicating that the primary route of excretion of DMSO is through the urine (Kolb et al., 
1967; Wong and Reinertson, 1984) . 
In beagles, elimination of DMSO after single and repeated cutaneous, oral and 
intravenous administration was studied. Results revealed that elimination depends on the 
way of application. After intravenous injection, one third of the injected dose was 
eliminated via the kidneys, indicating that the kidney is one of the organ of excretion. 
The elimination half time was about 36 hours whether by intravenous or oral 
administration. If DMSO was applied cutaneously, only 12 to 25 % was eliminated in the 
dog urine during the first twenty four hours, and 37-48% during a seven-day test period. 
Only a small fraction (0.5-2%) of an original dose of DMSO was excreted in the feces, 
regardless of the manner of application (Kolb et al ., 1967). 
The biological half life of DMSO after it is topically administered was reported to 
be greater than 10 hours in rats or dogs and 11 to 14 hours in people (Hucker et al, 
1967; Kolb et al., 1967). The elimination half time in rats was 6 hours by intravenous 
injection and 8 hours by cutaneous application, while in humans it was about four days 
(Kolb et al., 1967) . In horses, the biological half life of DMSO was determined to be 9-
10 hours by IV administration while urinary excretion of the parent drug accounted for 
approximately 26% of the dose over the first 12 hours (Blythe et al., 1986a). 
In all species, DMSO appeared in the urine earlier than DMSOi. Rucker et 
al.(1967) suggested that this might simply indicate differences in renal clearance or that 
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DMS02 was bound to tissues and slowly liberated. Another stud y also showed that 
DMSO was eliminated more rapidly than DMS02 in dogs. A dermal-applied , single dose 
required two days to clear DMSO and eight days for DMS02• Multiple doses required 3 
days to clear DMSO, 8-11 days to clear DMS02 (Hyde et al. , 1989). Law et al. (1991) 
reported that DMSO could be detected for 19 to 22 hours in horse urine after topical 
administration. 
From these facts, it can be summarized that DMSO and its metaboli tes are 
endogenous constituents of urine and plasma of man and animal. Its major 
pharmacological action is anti-inflammatory and analgesia. When administered to dogs, 
DMSO produces a variety of effects including anti-inflammation , analgesia, increased 
respiratory rates and depth , and stimulation of the central nervous system. The primary 
route of elimination of DMSO is th rough the urine. The major metabolite of DMSO is 
DMS02, which also has been proposed as an analgesic, anti-inflammatory compound. As 
analgesic , anti-inflammatory agents, these two compounds are of concern in pari-mutuel 
activities as possible performance-altering drugs . In order to prevent the possible misuse 
of DMSO and DMS02, all racing animals should be required by racing commission rules 
to have their bodily fluids analyzed for abnormal concentrations of DMSO and DMS02 
obtained from exogenous sources and not traceable to normal and ordinary feeding. 
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Analytical Consideration 
Numerous research papers have been published about the detection of DMSO and 
its metabolite DMS02 in biological samples using a variety of methods. The specific 
methods chosen by a laboratory will depend on a number of factors, including cost, 
workload, turnarou nd time, sensitivity required , and reliability. In nearly all applications 
of urine drug detection, a confirmation analysis is essential for all specimens screened 
positive. A different type of analytical methodology should be used for the confirmation 
analysis. 
Analytical methods used in most laboratories for the detection of drugs in body 
fluids can be classified into two main categories--immunoassay and chromatography--
generally used respectively for screening and confirmation (Hawks and Chiang, 1986) . 
Examples of these two types of methodologies are presented, including sections 
describing how they are used for screening and confirmation purposes. 
Sample preparation 
This step usually is to extract the DMSO, and its metabolites from the urine 
sample through either liquid-liquid extraction; solid-phase extraction, or any other means 
of separation from the biological matrix. This procedure is necessary to provide a 
relatively clean sample for analysis, thereby improving selectivity and precision and to 
concentrate the analyte, improving the sensitivity of analysis. 
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Liquid-liquid extraction remains a commonly used sample preparation technique in 
analytical chemistry. Drugs are extracted from biological samples by partitioning between 
two immiscible solvents. Since DMSO is an aprotic and a high polarity compound, which 
makes the extraction of DMSO from aqueous media more difficult, an inorganic salt 
(sodium chloride or potassium pyrophosphate) must be added to the sample first. This is 
called the salting-out technique (References from Racing chemistry laboratory, veterinary 
diagnostic laboratory, ISU. , Law et al. , 1990). Salting out can be used generally in 
solvent extraction. There are various reasons why salting out may be successful: (1) the 
high background electrolyte concentration alters the activities of the extracted species in a 
manner favoring extraction; (2) the salting out agent is solvated by water molecules. 
Because of its high concentration, a significant proportion of "free" water molecules are 
removed and the effective concentration of the extractable species in the aqueous phase is 
increased. When an organic extraction solvent , such as dichloromethane or ethyl acetate 
is added and completely dispersed, the vast majority of the compound is extracted into 
the organic layer. Repeating the process of extraction three times , with a fresh volume of 
the organic solvent each time, ensures the maximum recovery of the compound from the 
urine. This is known as a exhaustive salt out ex traction. The combined extract is 
concentrated to a small volume under nitrogen at room temperature, and the concentrated 
extract can then be utilized for further screening procedure. 
In the experiment of present studies, the polar organic extract should not be 
evaporated to dryness at temperatures higher than room temperature because both DMSO 
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and DMS02 are volatile compounds and may vaporize at higher temperature. The 
disadvantages of exhaustive salt out extraction are the time required for multi-step 
extractions and the variable recovery of the analyte. 
Optional sample preparation method for DMSO is protein precipitation by 
perchloric acid or methanol following by neutralization techniques (Garretson and 
Aitchison, 1982) or protein precipitation by acetone followed by separation on a porapak 
Q column (Mehta and Peaker, 1986) . These techniques are reported to give clear solution 
results, and consequently there is less protein built-up in the injection port of gas 
chromatography. 
Thin layer chromatography 
Thin layer chromatography (TLC) has been regarded traditionally as a simple, 
rapid , and inexpensive screening method for the initial separation , tentative identification, 
and visual semiquantitation of a wide variety of substances in biological sample. When 
compared with instrumentational techniques such as gas chromatography and high 
performance liquid chromatography , TLC usually has not been considered to be as 
sensitive or quantitative. 
TLC is a mode of chromatography in which the sample is applied as a small spot 
to the origin of an adsorbent (stationary phase) , such as silica gel, cellulose supported on 
a glass plate. A solvent mobile phase moves through the stationary phase by capillary 
action , allowing the substances to separate. The separated substances can then be 
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identified by sprayed with chemical reagents for characteristic color reaction. Drugs 
visualized in this way are identified on the basis of (a) reference values (ratio between the 
distance the mobile phase moves up the plate and the distance the compound moves from 
the point of application), (b) metabolic patterns (parent drug and characteristic 
metabolite), and (c) functional group analysis (chemical characteristics as defined by the 
color reaction with the spray reagent). The Rf value will vary according to the varying of 
the mobile phase strength and stationary phase. 
Advantages of using TLC include: (1) low cost of equipment, (2) rapid analysis, 
and (3) ability to detect more than one drug or metabolite per analysis. Relatively small 
amounts of drugs can be detected, usually as low as of 0.5-1.0 micrograms per milliliter. 
Some of the disadvantages of TLC are that it provides only fair specificity and 
sensitivity. It does require practice to recognize patterns of drugs and their metabolites by 
the visualized colored spots (Hawks and Chiang, 1986). 
Gas liguid chromato~raphy 
Gas liquid chromatography (GLC) is based upon the partition of the analytes 
between the stationary phase (solid support coated wHh a thin layer of a liquid phase) and 
the inert mobile carrier gas phase. Analytes must be thermally volatile and stable. For 
low volatility compounds, derivati zation may be needed to render the analytes more 
volatile. Packed columns and capillary col umns are commonl y used in GC . 
The detectors of GC generally are of three basic types: (1) Flame ionization 
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detector; (2) Electron capture detector; (3) Simplified mass spectrometric detectors such 
as the mass selective detector and ion trap detector. Since the flame detector and mass 
spectrometric detector are commonly used in our study , their principles will be discussed 
in detail later. 
The basic working principle of GC is based upon the injected sample volatilizing 
to a gas on the column resulting in the various fractions of the gaseous sample moving 
through the column at different rates due to physicaJ interaction with the stationary 
column phase resulting in the anaJyte appearing at different times (RT value) to the 
detector. The length of time for each maximum of the peaks to appear on the strip chart 
recorder , from the injection time, is the retention time (RT). RT is characteristic of the 
substance of interest and the liquid phase at a given temperature with proper flow and 
temperature control. The degree to which a GC system can reproduce Rt must be 
characterized. The retention time, therefore, qualitates the substance in the sample and 
the peak area quantitates the amount of each of the fractions present. The minimum 
detectable quantity is that amount which gives a detector response equal to twice or three 
ti mes the noise level (McNair and Bonelli , 1969) . 
A number of methods have been proposed for quantitating DMSO, using gas 
chromatography for the final stage of isolation and quanti tation with variations in sample 
preparation, columns, and detectors. Various chromatographic parameters , column, and 
obtaining various results for the analysis of DMSO and DMS02 are listed in Table 1. 
In the literature, the commonly used columns for DMSO and DMS02 analysis are: 
Table 1. Operating conditions and detection limits of dimethyl sulfoxide and dimethyl sulfone concentrations 
measured by gas liquid chromatography using flame ionization detection. 
ARTICLE 
Harold et al. , 1966 
Andreae, l 980a 
Garretson and Aitchison, 1982 
Mehta and Peaker, 1986 
COLUMN OVEN 
SPECIFICATIONS TEMP. 
4 ft.x.25 inch I.D. 220 °c 
6 m x 4.8 mm I.D. not given 
64 cm x .2 cm I.D. 190 °c 
2 m x 3.0 mm 1.0. 240 °c 
CARRIER 
GAS 
Helium 
Helium 
Nitrogen 
Nitrogen 
DETECTION 
LIMIT 
22 ng/ml 
0.02 ng/ml 
10 ng/ml 
100 ug/ ml 
DETECTOR 
TYPE 
FID 
FID/FPD 
FID 
FID 
IV 
w 
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(1) packed glass columns (Mehta and Peaker, 1986; Garretson and Aitchison , 1982), (2) 
capillary column (Law et al. , 1990; Law et al., 1991), (3) packed stainless column 
(Andreae, 1980a). 
The commonly used detectors are: (1) flame ionization detector (FID) or flame 
photometric detector (FPD), (2) mass spectrometry with selective ion monitoring (MS-
SIM) . The FID is an ionization detector that exhibits a nearly universal response to all 
organic compounds. The basic principle of operation is based upon the introduction of an 
organic compound into a hydrogen-rich or hydrogen-air fl ame jet resulting in the 
compound's ionization and an increase in the detector current above the background level 
between the flame jet and a collector electrode above the fl ame. In the li terature, the 
reported detection limit of DMSO concentration employing a fl ame ionization detector 
ranges from 0.02 ng/ ml S (DMSO) (Andreae, 1980a) to 100 ng/ ml (DMSO) (Garretson 
and Aitchison, 1986). 
In terms of DMSO detection, it is possible to use a FPD (sulfur-phosphorus flame 
photometric detector), because DMSO contains sulfur atoms (Patterson et al., 1978). This 
detector operates on the principle that S2 molecules from sulfur containing compounds, 
and HPO molecules from phosphorus compounds, emit characteri sti c light at specific 
wavelengths (blue and green) in hydrogen-ai r fl ame. A tilter is used to screen out al l 
other wavelengths so that only the proper wavelength reaches the photomul ti plier tube 
(PMT). A current is generated by the PMT which corresponds to analy te peak in the 
chromatogram. 
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Adequate reproducibility (precision) of the method was indicative of a coefficient 
of variation (C.V.) of 5 %-10%. A linear regression analysis was performed for X as the 
peak area ratio and Y as the known concentration. A correlation coefficient of 0.99 or 
greater is indicative of excellent linearity. 
GLC is a sensitive techn ique, and small amounts of drugs can easily be detected 
and identified by determining their respectj ve retention times as compared with known 
drug standards under optimum instrument conditions. Some of the limiting factors are (1) 
the slowness of analysis, (2) the expertise required in conducting the tests, and (3) the 
sample preparation time. Additjonally, GLC suffers from the deficiency that the retention 
time, which provides only a single para meter , cannot be used as an unequivocal 
identification in many cases (Hawks and Chiang, 1986). 
The anaJyticaJ technique of gas chromatography mass spectrometry (GC/MS) 
combines the efficient separating power on gas chromatography with the high sensitivity 
and specificity of mass spectrometric detection. GC/MS is generally considered to be the 
most conclusive method of confirming the presence of a drug in urine (Hawks and 
Chiang, 1986). Within most forensic racing laboratories, drug confi rmation by 
GC/MS is performed using quadrupole mass spectrometry with positive ion collection and 
electron impact (EI) ionization techniques. The application of a mass spectrometer as a 
universal , yet extremely selective and sensitive detector in gas chromatography has 
revolutionized the identification and measurement of organic compounds. 
The principle of operation of the mass selective detector is based on the fact that 
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when the sample enters a high vacuum ion source via the capillary column where the 
molecules can freely move in the evacuated space, they are bombarded into their 
constituent fragment ions by electrons emanating from the filament. The positively 
charged ions produced are propelled out of the source and focused into the quadrupole 
mass filter . When specific voltages are applied to the quadrupole rods, only ions of a 
specific mass-to-charge ratio pass from the ion source through the quadrupole to the 
detector without annihilation. After the ions are separated on the basis of mass-to-charge 
ratio , they are then counted as they enter the detector. The detected ions can be plotted 
graphically with the mass on the x axis and the counted ions (abundance) on the y axis to 
give a mass spectrum. Also, the abundance of all the ions can be plotted as a function of 
time to give a total ion chromatogram or, alternatively, selected ions can be monitored 
and plotted as a function of time (selected ion chromatogram). 
There are several different modes of operating a GC/MS. It can be operated in the 
"full scan" mode which provides a complete mass spectrum for each component of the 
urine extract that passes through the gas chromatography. Since a complete mass 
spectrum represents a "fingerprint" pattern that is unique for each drug , this mode of 
operation will give the most conclusive identification if there is a sufficiently high 
concentration of the drug to provide a good quality mass spectrum . In selected-ion-
monitoring mode (SIM), ions specific for the compound of interest are monitored rather 
than the entire AMU range. This mode of operation affords far higher sensitivity, but 
provides a less specific pattern for identification. 
Table 2. Operating conditions and detection limits of dimethyl sulfoxide and dimethyl sulfone concentrations 
measured by gas liquid chromatography using mass spectrometric detection. 
ARTICLE COLUMN OVEN CARRIER DETECTION 
TEMP. GAS LIMIT 
Garretson and Aitchison, 1982 107 cm x .2 cm l.D. 170 °c Helium 10 ng/ml 
Law~ al. , 1990 10 m x .2 mm l.D. 180 °c Helium 3-5 ng/ml 
Law~ fil. , 1991 10 m x .53 mm l.D. 150 oc Helium 3-5 ng/ml 
t-..) 
-...l 
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The choice of which modes of operation to be used depends on what drugs are to 
be detected, the minimum concentration of the drug that constitutes a positive 
identification, and whether or not the concentration of the drugs is to be quantitatively 
determined. The reliabili ty of a GC/MS assay is also dependent on the skill and 
experience of the operator, as well as on the method used for extraction of the drug(s) 
from the urine and for preparation of the extract for injection into the GC/MS. 
Several papers in the literature described detection of DMSO and DMS02 using 
GC/MS techniques (Garretson and Aitchison , 1982; Law et al. , 1990; Law et al., 199 1) . 
Quantitative analyses were performed by selected ion monitoring (m/e 63 and m/e 66 for 
DMSO; m/e 79 and m/e 82 for DMS02) (Law et al., 1990; Law et al., 199 1). Their 
studies have concluded that the proposed urinary DMSO threshold in horses was 15 ppm. 
Various other important chromatographic parameters and the detection limits for the 
analysis of DMSO and DMS02 are listed in Table 2 . 
Hieh performance liquid chromatoeraphy 
High performance liquid chromatography (HPLC) has been used as a drug 
screening method for some time. It is a highl y versatile technique that provides very good 
resolution and , unlike GC, is not adversely affected by the analyte's polarity or lack of 
volatility. 
HPLC can be easily interfaced with visible, ultraviolet (UV) and fluorescence 
detectors. Other detectors of limited use are electrochemical and mass spectrometric 
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detectors. The combination of HPLC with UV detection offers a good balance between 
efficiency and specificity. Every compound exhibits a characteristic ultraviolet or visible 
spectra which can be used to qualitatively identify it, and each compound will have a 
characteristk HPLC RT value associated with it. Being able to obtain both retention and 
spectral information about a compound within the same analytical process is an efficient 
way to gain information about a compound's identity. HPLC has the advantage that polar 
drugs requiring derivatization on GLC systems can be assayed directly on HPLC. Its 
disadvantages are similar to those of GLC. 
To detection of DMSO in environmental water samples, Ivey and Haddad used ion 
exclusive chromatography with a polymeric cation-exchange column and a UV detector 
(Ivey and Haddad, 1987). The detection limi t was reported to be 10 ppb with a 200 µI 
injection volume. DMSO has Emax of 195 nm with strong absorbance of UV light (Ivey 
and Haddad, 1987). No publication was found in the literature about analysis of DMSO 
in biological samples using HPLC technique. 
Comparative studies 
Many studies have been done using different methods to detect DMSO and its 
metabolites on an individual basis (Pau lin et al., 1966; Jursik , 1967; Andreae, l 980a; 
Mehta and Peaker, 1986; Ivey and Haddad, 1987; Hyde et al., 1990; Law et al., 1990). 
In addition, one publication has reported the results of GC vs. isotope dilution-mass 
spectrometry comparative study (Garretson and Aitchison , 1982) . T he author indicated 
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that there was no difference in the ability to ascertain DMSO presence in biological 
samples between the two assay methods. 
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EXPERIMENTAL 
Material and Instrumentation 
Instrumentations of GC and GC/MS 
Perkin Elmer model 3920B GC instrument equipped with a sulfur-phosphorus 
flame photometric detector (FPD) was utili zed in obtaining GC/ FPD results. Samples 
were separated using a DB-WAX capillary column (15 m X 0.53 mm fused silica with 1 
µm film thickness, J&W Scientific, Rancho Cordova, CA) . 
A Hewlett Packard model 5890 GC instrument connected to a Hewlett Packard 
5988A quadrupole mass spectrometer was used in quantitative analysis of drugs . A HP 
data station was equipped with the GC/ MS for mass spectral collection (electron 
ionization and positive ion collection). All GC/MS analyses were performed usi ng a DB-
WAX capillary column, 15 m x 0.25 mm fused si lica with 0.3 µm phase loading. 
Solvents. chemicals and reaeents 
Dimethyl sulfoxide utilized for dosing and for preparation of stock standard and 
spike was obtained from Fisher Scientific, Inc. (Fair Lawn, NJ). Dimethyl sulfone used 
for stock standard and spike preparations were obtained from Sigma Chemical Company, 
Inc. (St. Louis, MO). 
Hexamethyldisilazine (HMDS) and pyridine fo r silanization of glassware were 
acquired from Pierce Chemical Company (Rockford , IL) and Aldrich Chemical 
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Company, Inc. (Milwaukee, WI) respectively. 
All organic solvents used in this research were Fisher HPLC grade or equivalent 
and chemicals/ reagents used were reagent grade or better. Most chemicals and reagents 
were purchased from Fisher Scientific (Fair Lawn, NJ) including : sodium chloride, 
dichloromethane, potassium permanganate, acetonitri le and methanol. Potassium 
pyrophosphate was obtained from Aldrich Chemical Company, Inc. (Milwaukee, WI) 
All gases (nitrogen, air, helium , hydrogen, and high purity helium used in the 
GC and GC/MS were obtained from Air Products, Des Moines, IA. 
Other supplies 
Graduated wide mouth specimen containers for in itial urine collection and final 
storage were purchased from Cole-Parmer Instrument Company, Inc. (Chicago, IL). 
Screw top test tubes (16 x 125 mm) with PTFE lined caps used in the liquid-liquid 
extraction steps were purchased from Fisher Scien ti fic. Thin layer chromatography 
separations were performed on Kiesel silica gel 60 plates (normal phase) with F254 
fluorescence indicator purchased from EM Science, Gibbstown , NJ. 
Pipetmen precision microliter pipettes, utilized in all procedures for liquid 
dispensation were purchased from Rain in Instrument Company, Inc. (Woburn, MA). 
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Drug Administration and Sample Collection 
Canine dosin2 experiments 
Nineteen retired racing greyhounds, were used for thi s study. The animals ranged 
from 2-5 years in age and weighed from 15-28 kg. These animals received daily walking 
exercise. The dogs were held in a isolation without drug treatment for two weeks prior to 
any study to assume they had no drug bodyburden. They were held in caged mini-runs 
with water provide. A high protein, low fat, dry dog chow (Science diet) was fed once 
daily. Urine was obtained by a cup-on-a-stick volunteer collection at approximated 10:00 
a .m daily . The samples were capped, labeled, and stored at - 10 °c. 
Dimethyl sulfoxide administration studies 
Two retired racing greyhounds, # 8180 and # 10325, weighing approximately 22 
kg were chosen for a study of 1 ml/ per animal dermal exposure. Dogs# 8180 and # 
9577 were chosen for a study of 200 ul/ per animal dermal exposure. The DMSO liquid 
was applied directly to the test subject's skin (along the dorsal hair line). Due to the 
volatility of the DMSO, some of the drug evaporated into the surrounding air. No attempt 
was made to eliminate inhalation of this volatile fraction as a source of exposure in the 
test dogs . Urine was collected using the same procedure previously mentioned. Following 
DMSO administration , urine was collected at the times post admin istration indicated in 
Table 3. Prior to use, all glassware was rinsed thoroughly with acetone to remove any 
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Table 3. Collection times of urine following 1 ml/per dog and 200 ul/per dog DMSO 
administration from dogs # 8180, # 10325 and # 9577, respectively 
Time Post Dose Urine (DMSO 1 ml) Urine (DMSO 200 ul) 
#8180 #10325 #8180 #9577 
0 hour xx xx xx xx 
2 hour xx xx xx xx 
4 hour xx xx xx 
6 hour xx xx xx 
8 hour xx xx xx 
24 hour xx xx xx xx 
48 hour xx xx 
72 hour xx xx 
96 hour xx xx xx 
120 hour xx xx xx 
144 hour xx xx 
xx indicates urine sample was collected at the time 
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interfering chemicals. To prevent drug adsorption to glass, all micro vials utilized in GC 
and GC/MS analyses were initially silanized by heating at 60 °c with a 5 % HMDS in 
pyridine solution for one hour. The vials were then rinsed with acetone and used in the 
analyses. 
Analytical Methods 
Liqu id-liquid extraction (DMSO admini trated a nd blank urine) 
In order to extract DMSO and its metabolites from urine (both dosed and blank) 
by classical liquid-liquid extraction, an exhaustive salt-out extraction procedure was 
employed. When extracting dosed and blank urine samples for analysis via TLC and 
GC/MS, two ml of urine at each collection time for both dogs were used. 
After thawing in warm water, 2 ml of urine were dispensed into each of labeled 
screw top test tubes. One gram of sodium chloride was added to each tube and vortexed 
for 5 seconds. The samples were extracted three times with 4 ml of methylene chloride 
(DCM). Extracts was combined and the DCM layer was concentrated in pre-graduated 
nipple vials to 200 µl under nitrogen, then capped and vortexed for TLC and GC/MS 
analysis. For GC/MS analysis, 1 µI of the final extract was injected into the GC/MS. For 
TLC analysis, 5 µl or 10 µl of the extract were plated on a TLC plate. 
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Liquid-liquid extraction CDMSO spiked water and urine) 
After thawing in warm water , 2 ml of blank urine or water was spiked at the 
folJowing concentrations of DMSO/DMS02 : 0.5 ppm, 1.5 ppm, 2.5 ppm, 5 ppm, 10 
ppm, 15 ppm, and 20 ppm. Extraction of the DMSO/DMS02 spikes was performed using 
the same extraction procedure previously defined. 
Thin-layer chromatographic techniques 
All TLC analysis was performed on Kiesel silica gel 60 TLC plates . For 
DMSO/DMS02 analysis, the extracts were developed on the plate for a distance of 5 
centimeters from the origin with Davidow development system, (ethyl 
acetate:methanol:ammonia 8.5 : 1.0 : 0.5) , made fresh daily . 
Following development, plates were visualized under short and long wave 
ultraviolet light for quenching and fluorescence respectively, Then, the plates were 
sprayed with potassium permanganate (1 % in H20). DMSO was oxidized by potassium 
permanganate to give a yellow color spot, DMS02 is not oxidized by potassium 
permanganate and is not observed by TLC. 
Gas chromatographic techniques and conditions 
All GC-FPD analyses of DMSO/DMS02 were done using a J&W DB-WAX fused 
silica column (15 m x 0.53 mm with a 1 micron loading phase) , with a Perkin-Elmer 
3920 B gas chromatograph equipped with a su lfur-phosphorus FPD detector. 
Conditions for GC/FPD were : 
Detector temp. 
Oven temp. 
Carrier gas flow(nitrogen) 
Hydrogen 
Air 
Injection mode 
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200 °c 
90 °c 
30 ml /min. 
50 psi 
50 psi . 
on column 
All GC/ MS analyses were done usi ng a J&W DB-WAX fused silica columns (15 
m x .25 mm with a 0. 3 micron loading fi lm th ickness) . All extracts were injected without 
derivatization or thin-layer clean up . The ana lyses were performed with a Hewlett 
Packard 5890A gas chromatograph connected to a Hewlett Packard 5988 quadrupole MS. 
Conditions for GC/MS were: 
Injector temp: 
Oven temp: 
Carrier gas (He): 
Injection mode: 
Electron energy: 
Source temp: 
Ionizer vacuum: 
200 °c 
70 °c hold fo r 1 min , programmed at 20 °C/ min to 150 °c 
1 ml/ min flow rate 
Splitless 
70 eV 
265 °c 
< 10·6 torr 
38 
Blank and dosed urine were analyzed by GC/MS in full scan (40-100 AMU) mode 
with EIC (extract ion chromatogram) or TLC (total ion chromatogram) data interpretation 
techniques and SIM mode with SIC (selected ion chromatogram) data interpretation 
technique. The ions monitored were m/z 63 and 78 for DMSO and m/z 79 and 94 for 
DMS02• 
The GC/ MS instrument was operated in the EI mode, the quadrupole mass axis 
was calibrated using the ions m/e 69 , 219 and 502 from the perfluorotributylamine 
(PFTBA) with an ion source of 200 °c and an electron energy of 70 eV. 
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RESULTS AND DISCUSSION 
Analytical Methodology 
The choice of a valid analytical procedure is an obvious and important factor in 
achieving results of high quality. The specificity, sensitivi ty , and reproducibility of the 
method must be known in order to achieve the quality goals selected previously. 
Limit of detection 
The ability of any assay to detect low levels of drugs has an inherent limit. The 
concentration of drug in the urine sample below which the assay can no longer be 
considered reliable is the "detection limit" . By comparing the detection limits of the 
various methods, some knowledge can be obtained regarding the useability of the 
respective methodology. In this work, it is especially important to obtain the accurate 
information about the detection limits of the various methods. 
TLC For all thin-layer work, the TLC plates were developed for a distance of 
five centimeters with a solvent consisting of ethyl acetate:methanol:ammonia (8:5: 1). 
Following plating and development of DMSO standards on TLC plates, neither quenching 
or fluorescing were observed under SWUV and LWUV visualization. Lastly, the plates 
were sprayed with potassium permanganate, and the spots of interest were then visible on 
the plate. DMS02 was not observed by TLC. The Rf value for DMSO is 0.22. 
Concentrations of 4, 3, 2, 1, and 0.5 µg DMSO standard present on the TLC 
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plate were developed, visualized under UV light, and then sprayed with the spray 
reagent. All concentrations higher than , and including I µg , were visible to the naked eye 
at the Rf value of interest. Below 1 µg DMSO the ability to vi sualize the spot of interest 
with the naked eye was very difficult. When taken into consideration that an actual TLC 
plate would contain a large number of samples, each with endogenous constituents 
becoming visible following spraying , the lowest detectable level of DMSO would have to 
be classified as approximately l µg on the TLC plate. 
GC/FPD Gas chromatography with sulfur-phosphorus detection had a detection 
limit for DMSO and DMS02 equal to approximately 20 ng and 100 ng on col umn with a 
signal/noise (peak height) ratio equal to or larger than three, respectively. Below 20 ng 
DMSO and 100 ng DMS02 the signal/noise was smaller than two. Figure 2 and 3 
illustrate a DMSO standard curve and a DMS02 standard curve by GC/FPD. Figure 4 
shows a typical GC/FPD output. 
GC/MS Analysis of DMSO and DMS02 were done using the total abundance of 
ions m/e 63, m/e 78, m/e 79, m/e 94 and TIC (total ion chromatogram) in full scan and 
SIM mode. Both compounds were detected by the presence of major two ions. For 
DMSO, the base ion is m/e 63 , and the molecular ion m/e 78 is present at 50% of the 
base ion. For DMS02, the base ion is m/e 79, and the molecular ion m/e 94 is present at 
50% of the base ion. Gas chromatography/mass spectrometry detection in full SCAN and 
SIM mode had detection limits for DMSO equal to approximately 3.0 ng and 0.6 ng with 
a signal/noise (peak area) ratio equal to or larger than three, respectively. Detection 
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limits in full scan and SIM mode for DMSOi were found to be 3.0 ng and 0.6 ng with a 
signal/noise (peak area) ratio equal to or larger than three, respectively. Below 3 .0 ng 
and 0.6 ng the signal/noise ratio was smaller than two. Figure 5a, 5b, 6a, 6b, 7a, 7b, 8a, 
and 8b illustrates a DMSO standard curve and a DMS02 standard curve under both full 
scan mode and SIM mode. Curve b is the enlarged lower range of curve a. 
Reproducibility 
Precision studies have to be performed in the analytical measurements for quality 
assurance. The reproducibility of the each method was studied by calculating the standard 
deviation (SD) and coefficient of variation (CY) at each standard level. 
GC/FPD The method precision was obtained by quantitatively analyzing two 
DMSO/DMS02 standards: 20/100 and 301150 ng. Table 4 represents the statistical 
analysis, mean, SD and CY of the within day precision at each of the two concentrations 
tested. Results seem to indicate that the analysis method has a poor reproducibility. 
Within-day coefficients of variation (C.V.) ranged from 7.61 to 41.13 %. No day-to-day 
precision analysis was performed in this study. Figure 9 shows a typical GC/FPD output. 
GC/MS The GC/MS precision was obtained by quantitatively analyzing five 
DMSO/DMS02 standards: 30/30, 50/50, 60/60, 70/70 , and 80/ 80 ng in full scan mode. 
The within-day precision was obtained by injecting each standard five times within 24 
hour period. Table 5 represents the stati stical analysis, mean, SD, CV of the within-
day precision of the five standards tested. DMSO peaks were integrated using the 
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Table 4. Statistical analysis of with in-day precision study by GC/FPD . 
Number of Level of Mean of SD of CV, % 
Analyses Standards Peak height Peak height 
6 20 ng DMSO 4.55 ± 0. 67 14.7 
6 100 ng DMS02 2.68 ± 0.20 7.61 
8 30 ng DMSO 7.36 ± 3.01 41.13 
8 150 ng DMS02 3.95 ± 1.21 30.74 
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Table 5. Statistical analysis of within-day precision study by GC/ MS in full scan mode 
(DMSO and DMS02 peaks were integrated using total ion chromatogram). 
Number of Level of Mean of SD of CV , % 
Analyses Standards Peak area Peak area 
5 30 ng DMSO 4545.2 ± 266.9 5.9 
5 50 ng DMSO 7438.2 ± 143.3 1.9 
5 60 ng DMSO 10487.8 ± l l l.O 1. l 
5 70 ng DMSO 11571.4 ± 441.0 3.8 
5 80 ng DMSO 13436.8 ± 536.5 4 .0 
5 30 ng DMS02 2853.6 ± 122.9 4.3 
5 50 ng DMS02 4969.8 ± 166.7 3.4 
5 60 ng DMS02 6995.6 ± 15 1.6 2.2 
5 70 ng DMS02 85 17.4 ± 133.2 1.6 
5 80 ng DMS02 865 l.2 ± 348.3 4.0 
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molecular ion m/e 78, DMS02 peaks were integrated using the molecular ion m/e 94. 
Reproducibility of the method was verified by five standards with within-day 
coefficients of variation (C.V.) of 1.1 to 5.9% for DMSO and C.V. of 1.6 to 4.3% for 
DMS02• A four-point calibration curve was prepared for every batch of samples. A urine 
blank and two urine samples spiked with a known concentrations of DMSO and DMSOi 
(10/10, 15/15 ppm) were included in every batch of samples as control samples. 
The day-to-day precision was verified by injecting five standards within five days , 
respectively. Table 6 gives the statistical analysis, mean , SD, CV of the day to day 
precision of the five standards tested (50/50, 1001100, 150/150, and 200/200 ng). Both 
DMSO and DMS02 peaks were integrated using total ion chromatogram (TIC). Day-to-
day coefficients of variation (C. V .) ranged from 3.3 to 9.2 % for DMSO, and 3.5 to 
7.3 % for DMS02 • A four-point calibration curve was constructed every day. A blank 
urine sample and two urine spikes (10/ 10, 15/15 ppm) were also included in every day 
analysis. Two stock DMSO and DMS02 standards (1 µg/ µl) were used for all standard 
curves preparation and spiking. 
Average spike recoveries and day-to-day coefficients of variation were determined 
with these urine spikes. Results are given in Table 7. Figure 10 and Figure 11 represent 
the typical results of within-day precision study by showing a DMSO and a DMS02 
standard curve with error bars indicating 2 SD, n = 5 . 
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Sample spikes 
Extraction of DMSO, DMS02 aqueous spikes and urine spikes was performed to 
determine the extraction efficiency and reproducibility of the method for the analyte of 
interest in biological and aqueous matrices. Spike recoveries and within day coefficients 
of variation were determined using these spikes. 
TLC Two ml of blank dog urine were spiked with DMSO and then extracted by 
the sodium chloride exhaustive salt-out procedure. Urine was spiked at the following 
concentrations: 5, 10, 25, 50, 75, and 100 ppm. After extraction and concentration, 5 µl 
of the final 200 µl extract were spotted on the TLC plate. For reference, DMSO standard 
was spotted on each side of the TLC plate. The TLC plate was then treated with the 
approximately solvents and sprays indicated in the Materials and Methods. Typical 
pictures of DMSO water and urine spikes on a TLC plate are represented in figure 12 
and 13. All concentrations greater than or equal to 50 ppm were visible to the naked eye 
at the Rf value of interest. Below 25 ppm DMSO the ability to observe the color spot of 
interest with the naked eye was greatly impaired. The lowest detectable level of DMSO 
urine spikes on TLC plate was estimated at approximately 50 ppm. For aqueous spikes, 
using the same procedure, the detection range of DMSO water spikes was extended to 
approxi ma tel y 25 ppm. 
For both aqueous spikes and urine spikes visible on TLC plates, after spraying, 
the color reaction can be seen immediately . However, it is obvious that the detection 
range of the aqueous spike is lower than that of the urine spike. It is assumed that the 
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Figure 9. GC/FPD output of reproducibility 
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Table 6. Statistical analysis of day-to-day precision study by GC/MS in full scan mode 
(DMSO peaks were integrated using ion m/e 78, DMS02 peaks were integrated 
using ion m/e 94). 
Number of Level of 
Analyses standards 
6 60 ng DMSO 
6 100 ng DMSO 
6 150 ng DMSO 
6 200 ng DMSO 
6 60 ng DMS02 
6 100 ng DMS02 
6 150 ng DMS02 
6 200 ng DMS02 
Mean of 
peak area 
53352.2 
115514.2 
151976.5 
218499.0 
50869.0 
93 125.3 
144906.7 
219550.5 
SD of 
Peak area 
± 2734.4 
± 3823.8 
± 103 14.5 
±20285.8 
± 1997.2 
± 3246.8 
± 8079.9 
± 16154.5 
CV % 
5.1 
3.3 
6.8 
9.2 
3.9 
3.5 
5.6 
7.3 
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Table 7. Percent recovery and day-to-day coefficients of variation of spiked urine samples 
by GC/MS in full scan mode. 
Number of concentration Mean of SD of CV, % 
Analyses (ug/ml) recovery % recovery 
DMSO 
8 10 47.9 ±6.5 18.3 
8 15 48.9 ±5.2 15.1 
DMS02 
8 10 107.5 ±13.4 19.9 
8 15 109.5 ±14.1 21.5 
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Figure 12. Thin-layer chromatographic results of DMSO spikes following salt 
out extraction of 2 ml urine. 
Spray sequence = 1 % potassium permanganate. 
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Figure 13. Thin-layer chromatographic results of DMSO spikes following 
salt out extraction of 2 ml water . 
Spray sequence = 1 % potassium permanganate 
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result is reasonable because the endogenous background in urine spike may interfere with 
the extraction. In order to increase spike recovery of DMSO, these same spikes were also 
extracted by potassium pyrophosphate exhaustive salt-out extraction procedure according 
to the extraction procedure of the Law et al.(1990). They believed that better spike 
recovery might be obtained using potassium pyrophosphate instead of using sodium 
chloride, because the latter is more soluble in DMSO. However, in our experiment, the 
detection ranges of two methods were the same for both DMSO urine and aqueous spikes 
on TLC plates. In comparison , sodium chloride salt-out procedure was easy to perform. 
So, this method was chosen for all future DMSO/DMS02 extraction. 
GC/FPD No gas chromatography with sulfur-phosphorus detector analysis of 
urine spikes was performed in this study due to the lack of acceptable analytive 
reproducibility. 
GC/MS GC/MS was chosen for the DMSO/DMSOi spike recovery analysis 
because of the high degree of specificity, accuracy, and precision within the system. Two 
ml of the blank dog urine was spiked with DMSO/DMS02 at the following 
concentrations: 0.0, 0.5/0.5 , 1.5/l .5, 2.5/2.5 , 5/5, 10/10, 15/15, and 20/20 ppm. Spikes 
were then extracted by the salt-out exhaustive extraction procedure, and 1 µI of the final 
extract was injected into the GC/MS. For DMSO urine spikes, quantitative analysis was 
done by SIM mode with peak area of the molecular ion m/e 78 used to determine percent 
recovery. For DMS02 urine spikes, peak area of the molecular ion m/e 94 was used to 
determine percent recovery. Aqueous spikes were extracted and treated using the same 
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procedure and data was integrated in the same way. In urine, the spikes were detectable 
down to 0.5 ppm for DMSO and 1.5 ppm for DMS02 . In water, the spikes were 
detectable down to 0.5 ppm. 
Table 8 and Table 9 represent the percent recovery and within day coefficients of 
variation of the DMSO and DMS02 in urine and aqueous matrix by GC/MS in the SIM 
mode. The results indicate that at all concentrations listed, recovery of DMS02 urine 
spikes varied from 104.5 % at 1.5 ppm to 156.8 % at 20.0 ppm, recovery of DMSO 
urine spikes varied from 20.4 % at 0.5 ppm to 74.8 % at 20.0 ppm. The possible causes 
of spike recovery variability are: (1) multistage exhaustive ex traction method might cause 
variable recovery of the analyte; (2) loss of analyte during the concentration process 
might cause a lower recovery at lower spike level. 
Since both DMSO and DMS02 are possible endogenous compounds in dog urine, 
A blank urine sample (0.0 ppm) was also analyzed for the presence of both DMSO and 
DMS02, the background values of DMSO and DMS02 in blank urine were subtracted 
from final spike recovery calculation. DMSO spike recoveries were obviously lower than 
that of DMS02 at each spike level. The possible explanations for this phenomenon are (1) 
salting out does not improve extraction because many inorganic salts highly soluble in 
dimethyl sulfoxide, (2) the loss of DMSO during the concentration process because 
DMSO is more volatile than DMS02. However , within the forensic racing laboratories, 
this extraction method is sensitive enough for DMSO/DMS02 analysis of dog urine 
because it is relevant to levels found in doped dogs. 
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Table 8. Percent recovery of DMSO and DMS02 urine spikes by GC/MS in SIM mode 
(n=l). 
Spike (ppm) 0.0 0.5 1.5 2.5 5.0 10 15 20 
DMso· 4.4 8.9 27.8 47.9 99.9 227.6 377.6 584.2 
DMsoc STD 0.0 22. 1 61.4 99.4 196.1 389.1 582.0 775.0 
% Recovery 20.4 38.4 43.7 48.7 57.4 64. l 74.8 
DMS02b 287.4 209.1 343.2 428.2 641.0 794.9 1086.8 1463. 7 
DMS02d STD 0.0 16.9 53.4 9 1.2 185.3 373.6 561.9 750.3 
% Recovery 104.5 154.6 190.8 135.8 142.3 156.8 
Within day spike recovery coefficient variation (C.Y. % is 19.2 for DMS02, 21.7 for 
DMSO) 
1DMSO sample spike (area X 1000). 
bDMS02 sample spike (area X 1000). 
cnMSO standard (area X 1000). 
dDMS02 standard (area X 1000). 
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Table 9. Percent recovery of DMSO and DMS02 water spikes by GC/MS in SIM mode 
(n= l ). 
Spike (ppm) 0.5 1.5 2.5 5 .0 10 15 20 
DMSO" 5.8 29.3 46.7 78.0 217.6 271.4 397.6 
DMsoc STD 22.2 61.0 99.6 196.1 389.0 582.0 775. l 
% Recovery 26.2 48.1 46.9 39.8 55 .9 46.6 51.3 
DMS02b 12.3 64.8 88 .1 160.4 382.2 542.7 670.3 
DMS02d STD 15.6 53.5 91.1 185.3 373.6 561.9 750.3 
% Recovery 78.8 120.9 96.6 86.6 102.3 96. 6 89.0 
Within day spike recovery coefficient vari ation (C. Y. % is 14.1 for DMS02, 21.3 for 
DMSO) 
"peak area (m/e 78) X 1000 of sample spike 
bpeak area (m/e 94) X 1000 of sample spike 
cpeak area (m/e 78) X 1000 of DMSO standard 
<iJeak area (m/e 94) X 1000 of DMS02 standard 
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E ndogenous and Do ed Drug Concentrations 
Administration urine 
TLC Two ml of urine sample from dog # 8180 given DMSO at two dose levels 
(1 ml and 200 µ1 pure DMSO) were extracted with the salt-out exhaustive extraction 
procedure. These two dosages were chosen because it is important for us to know at 
which dosage DMSO levels can be distinguished from endogenous levels at certain 
postdose times in dog urine. 
Typical pictures of TLC results a re represented in figure 14 and 15. The results 
show that at 1 ml/per dog dose level , presence of the DMSO can be detected according to 
the currently accepted thi n-layer parameters up to approximately 24 hours post dose when 
10 µl of the extract are plated on TLC plate. After 24 hours post dose, the presence of 
DMSO on the plate was not visible to the naked eye. At 200 µI /per dog dose level, 
visualization to the naked eye of original DMSO administration was not possible. 
GC/MS Gas chromatography mass spectrum analysis of the administration urine 
from dog # 8180 and # 9577 at 200 µI dose level and from dog #8180 at I ml dose level 
was performed in full scan and SIM mode. A four-point standard curve and two control 
samples (spikes) were included in every batch of samples. The total peak area of ions 
were monitored for quantitation at m/e 63, m/e 78 for DMSO and m/e 79, m/e 94 for 
DMS02 • When analyzing the total abundance of ions m/e 63, m/e 78, m/e 79, and m/e 
94 in full scan mode, dog# 8180 reached maximum excretion of parent drug (DMSO) in 
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the urine at 6 hours post administration at both dose levels (I ml and 200 µl). It reaches 
maximum excretion of DMS02 in the urine at 8 hours post administration at both dose 
levels. Dog # 9577 reached maximum excretion of DMSO at 6 hours, and it attained 
maximum excretion of DMS02 at 8 hours post administration at 200 µl dose level. When 
analyzing the total abundance of ions m/e 63, m/e 78, m/e 79, and m/e 94 in SIM mode, 
at 1 ml/per dog dose level , dog # 8180 reached maximum excretion of DMSO in the 
urine at 6 hours post dose. It reached maximum excretion of DMS02 at 8 hours post 
dose. At 200 ul dosage, dog# 8180 reached maximum excretion of DMSO in the urine at 
8 hours post administration. It reached maximum excretion of DMS02 at 8 hours post 
dose. Results from pre-administration urine indicate both DMSO and DMS02 are 
endogenous constituents of greyhound's urine. From these results, it is obvious that in 
most cases the peak excretion of DMSO in dogs occurred at 6 hour post dose, the peak 
excretion of DMS02 happened at 8 hours post dose. 
Reproducibility and stability of the GC/ MS method in full SCAN mode for 
administered sample analysis were verified by injecting two administration samples three 
times within a 24 hour period (24 hours and 96 hours at 1 ml/per dog dose level) . 
Table 10 represents the statistical analysis results . When the variable analyte 
recovery factor is considered, this statistical results indicate that the method employed has 
a reasonable reproducibility and short term stability for administered sample analysis. The 
urinary excretion profiles for DMSO and DMS02 in two greyhounds after topical 
administration of DMSO (1 ml, 200 µI per dog dose level) in full SCAN mode and SIM 
, 
' . 
70 
Figure 14. Thin-layer chromatographic results from dog #8180 (1 ml per dog) 
following salt out extraction of 2 ml urine 
Spray sequence = 1 % potassium permanganate 
Arrows indicate the distance DMSO standard moves from the point of 
application 
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Figure 15. Thin-layer chromatographic results from dog #8180 (200 ul per dog) 
following salt out extraction of 2 ml urine 
Spray sequence = 1 % potassium permanganate 
Arrows indicate the distance DMSO standard moves from the point of 
application 
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Table 10. Statistical analysis of reproducibility and short term stability study by GC/MS 
in full scan for administered samples. 
Number of Post dose Analytes Mean" of SD of CY % 
Analyses Hours peak area peak area 
3 24 DMS02 2273 .4 ± 58.5 2.6 
3 96 DMS02 951. l ± 140.3 14.8 
3 96 DMSO 71.9 ± 7.5 10.4 
"peak area X 1000 
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mode are showed in Figures 16, 17, 18, 19, 20, 21, 22, 23, 24, and 25. 
Endo2enous levels of DMSO and DMS0 2 in the ereyhound urine 
Nineteen greyhounds ranged from 2-5 year in age were chosen for this study. 
Urine samples were drawn from each dog at 10 a.m every day. The research dogs were 
not exposed to any drugs during the urine collection period . Samples were stored at - 10 
°C until analyzed. After thawing in warm water, 2 ml of uri ne sample from each dog 
were then extracted by the salt-out exhaustive extraction procedure. Total extract was 
concentrated down to approximately 200 µI and transferred to a pre-graduated 
autosampling vial, 1 µl inj ected into the GC/ MS by autosampler. Samples were analyzed 
in full scan and SIM mode for dimethyl su lfoxide and dimethyl sul fone. 
A four-point calibration curve was constructed fo r every day analysis. The 
correlation coefficient was always better than 0. 99. A urine blank and two urine spikes 
were also included in every batch of samples as control samples. 
Usually , the initial mass spectral analysis of suspicious samples is routinely 
performed in full scan mode. The scan run allows for all ions within the sample to be 
detected, and then when a suspicious drug is thought to be present SIM mode will be 
performed by selectively looking at specific ions within the chromatogram. When 
analyzing the total abundance of ions m/e 63, m/e 78, m/e 79, m/e 94 in full SCAN 
mode, DMS02 can be detected by the presence of both major ions (m/e 79, m/e 94) with 
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the molecular ion m/e 94 present at 50% of the base ion m/e 79 in all of the blank 
samples, which make us believe that DMS02 is a normal constituent in dog urine. DMSO 
can also be detected by the presence of both major ions (m/e 78, m/e 63) with the 
molecular ion m/e 78 present at 50 % of the base ion m/e 63 in all of the blank samples, 
which indicates that DMSO is also a endogenous constituent in dog urine. In SIM mode, 
both DMSO and DMS02 were detected by the presence of two major ions (m/e 78, m/e 
63 for DMSO, m/e 79, m/e 94 for DMS02) in all blank dog urine samples. However, 
DMS02 concentrations were at much higher level compare to that of DMSO. It is 
believed that the increase on DMS02 level is too large to be due to the original DMS02 
alone and most of it must have arisen metabolically. 
Quantitative analysis of DMSO and DMS02 was done in SIM mode by integrating 
peak area of the molecular ion m/e 78 for DMSO, the molecular ion m/e 94 for DMSOi. 
Without applying the spike recovery factors, the absolute endogenous DMSO 
concentrations from 19 research dogs were presented in Table 11 with an average of 
552.5 ppb (SD=346.5). Two DMSO absolute concentrations (51694.8 and 2237.0 ppb) 
which do not fall into the 3 SD range were omitted. From urine spi ke recovery Table 8, 
it is obvious that spike recoveries of DMSO in urine were concentration dependent and 
varied predictably from 20.4 % at 0.5 ppm concentration to 74.8 % at 20.0 ppm 
concentration. After corrected by the spike recovery factors, endogenous DMSO 
concentrations from 19 research dogs covered a range from 1258.8 to 3827.8 ppb 
(Table 11). The average endogenous concentration of DMSO is 2383.4 ppb 
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Figure 16. DMS02 urinary extraction profile of dog #8180 following 
administration of l ml DMSO by GC/MS in full scan, n= 1 
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Figure 17. DMSO urinary extraction profile of dog #8180 following 
administration of 1 ml DMSO by GC/MS in full scan , n = 1 
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Figure 18. DMS02 urinary extraction profile of dog #8180 following 
administration of 1 ml DMSO by GC/MS in SIM mode, n = 1 
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Figure 19. DMSO urinary extraction profile of dog #8180 following 
administration of 1 ml DMSO by GC/MS in SIM mode, n = 1 
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Figure 20. DMS02 urinary extraction profile of dog #8180 following 
administration of 200 ul DMSO by GC/MS in full scan mode, n = 1 
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Figure 21. DMSO urinary extraction profile of dog #8180 following 
administration of 200 ul DMSO by GC/MS in full scan mode, n = 1 
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Figure 22. DMSO urinary extraction profile of dog #8180 following 
administration of 200 ul DMSO by GC/MS in SIM mode, n = 1 
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Figure 23. DMS02 urinary extraction profile of dog #8180 following 
administration of 200 ul DMSO by GC/MS in SIM mode, n = 1 
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Figure 24. DMSO urinary extraction profile of dog #9577 following 
administration of 200 ul DMSO by GC/MS in full scan mode, n = 1 
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Figure 25. DMS02 urinary extraction profile of dog #9577 following 
administration of 200 ul DMSO by GC/MS in full scan mode, n = 1 
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(SD=798.2). Endogenous concentration range of DMS02 in nineteen dogs varied from 
2.2 ppm to 164.8 ppm. From urine spike recovery Table 8, it can be seen that the 
percent recovery of DMS02 urine spike was above 100% at each spike level. One 
DMS02 concentration (309093.4 ppb) which falls to outside of the 3 SD range was 
omitted. The average endogenous concentration of DMS02 is 70.4 ppm (SD=50.4). The 
reasonable explanation of the variability are (1) variable detector, (2) variable analyte 
recovery. 
Figure 26 shows the comparative study between normal DMSO levels of 19 
research dogs and dosed DMSO levels for 144 hours post dose period of dog #8180 and 
#9577 at two subtheraputic use levels (DMSO 1 ml and 200 ul/dog). From the figure, it 
can be seen clearly that at 200 ul dosage all dosed DMSO levels of dog #8180 for 144 
hours post dose period are within the 2 SD range of normal DMSO level , However, 4 
and 6 hours post dosed levels of dog #9577 are not within the 2 SD range of normal 
levels. At this point, it is hard to draw a conclusion regarding the differentiation between 
the dosed DMSO levels and normal DMSO levels at 200 ul subtheraputic dosage. Further 
statistical analysis and more administration study are necessary for reaching the final 
conclusion. At 1 ml dose level, the farthest post dose time point at which DMSO level 
does not fall into the two standard deviation range of normal DMSO levels is 24 hours , 
which indicates that normal DMSO levels can be easily distinguished from dosed DMSO 
levels for 24 hours post dose even at subtheraputic use level 1 ml per dog. 
Figure 27 represents the similar comparative study between normal DMS02 levels 
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Table 11. Endogenous urinary concentrations of DMSO in 17 research dogs 
Absolute concentrations ppb 
186.3 
1068.5 
903.9 
501 .5 
873.7 
226.5 
766.0 
439.0 
1416.3 
276.6 
195.0 
403.0 
247.1 
595.8 
344.6 
433.2 
514.6 
Corrected concentrations ppb 
1258.8 
3561. 7 
3263.2 
2458.3 
3223.9 
1461 .3 
3039.7 
2286.5 
3827.8 
1686.6 
1308.7 
2155.1 
1563.9 
2708.2 
1957.9 
2256.3 
2498. 1 
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of 19 research dogs and dosed DMS02 levels for 144 hours post dose period of dog 
#8180 and dog #9577 at two subtheraputic use levels (DMSO 1 ml and 200 ul/dog). 
From the figure, it is obvious that all dosed DMS02 levels of two dogs for 144 hours 
post dose at 200 ul dosage are within the 2 standard deviation range of normal DMS02 
levels. The results mean that dosed DMS02 levels in dog #8180 and #9577 at 200 ul 
subtheraputic dosage can not be distinguished from normal DMS02 levels within the 2 SD 
range. At 1 ml dosage, the farthest post dose time point at which DMS02 urine level does 
not fall into the 2 SD range of normal DMS02 levels is 24 hours, which also indicates 
that normal DMS02 levels can be easily distinguished from dosed DMS02 levels for 24 
hours post dose at subtheraputic use level 1 ml per dog. These results provide very useful 
information for this work regarding urinary clearance kinetic and therapeutic use levels of 
DMSO and DMS02 in dogs at rest state. 
The results also help us to identify the important post dose time point regarding 
the differentiation between normal DMSO/DMS02 urinary levels and dosed 
DMSO/DMS02 urinary levels . However, fo r accurate determination of this crucial time 
point, more statistical analysis and administration study of DMSO and DMS02 in dogs 
will be needed in future work. 
Practicability 
The procedure and techniques utilized in th is work could be utilized in a routine 
drug testing program with these conditions. Chromatograph ic screen ing and confirmation 
88 
often necessitates extensive extraction and cleanup procedures prior to injection into 
the instrument, greatly increasing the time required for the analysis. The analysis of a 
large number of samples usually requires several days to finish just the extraction process 
and need more time to do the final confirmation and quantitation so that the results can be 
finalized. If when automatic instruments are available, the time can be greatly reduced . 
The chromatographic instrumentation such as GC/FPD and GC/MS require some 
degree of training in order to fully operate the instrument to its capacity and solve the 
problems encountered. 
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SUMMARY 
This study investigated the characteristics of analytical methods such as analyte 
recovery, detection ranges, specificity, reliability and precision, and determined 
endogenous levels of DMSO and DMS02 in a selected sampling of greyhound urine using 
the optimal method of choice. 
Gas chromatography with sulfur-phosphorus flame photometric detection method 
had poor sensitivity and reproducibility with standards, which make GC/FPD an 
undesirable method for detection of DMSO and DMS02• Thin layer chromatography was 
also indicated as a poor detection method in terms of sensitivity with standard and spikes. 
Gas chromatography/mass spectrometry showed much better reproducibility than the 
GC/FPD analytical technique. GC/MS in full scan or SIM results in acceptable curves 
with useful detection limits and specificity. The lowest detection limit of 0.6 ng for both 
DMSO and DMS02, was accomplished by GC/MS in SIM mode detection. 
GC/MS method was also indicated as being superior in terms of analytical 
specificity, sensitivity and reproducibility with pure standards and aqueous/urine-based 
spikes with DMSO and DMS02 • With spikes, the detection limit can be extended as low 
as 0.5 ppm in urine-based spikes for DMSO; 1.5 ppm for DMS02, and 0.5 ppm in 
aqueous-based spikes for both DMSO and DMS02• 
Among the classical analytical methods investigated, exhaustive salt out liquid 
liquid extraction assay was relevant to spiked and dosed urine samples. 
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A spike recovery study was done in SIM mode by analyzing both aqueous and 
urine spikes. Spike recoveries were concentration dependent and varied predictably from 
26.2% at 0.5 ppm to 51.3 % at 20.0 ppm for aqueous DMSO spikes, 78.8% at 0.5 ppm 
to 89.0% at 20.0 ppm for aqueous DMS02 spikes; For urine DMSO spikes, spike 
recoveries varied predictably from 20.4 % at 0.5 ppm to 74.8 % at 20.0 ppm . For urine 
DMS02 spikes, spike recoveries were above 100% at every spike levels. 
Administration study of DMSO and DMS02 in dogs was done in both full scan 
and SIM mode. Two subtheraputic dosages ( 1 ml and 200 ul/per dog) of DMSO liquid 
were topically administrated on the skin of two dogs of each group. In most cases, the 
peak excretion of parent compound DMSO occurred at 6 hours post dose, and the peak 
excretion of metabolite DMS02 happened at 8 hours post dose. 
Endogenous levels of DMSO in 17 research dogs averaged at 2383.4 ppb with a 
SD of 798.2 after corrected by spike recovery factors. Without correction of spike 
recovery factors, endogenous concentrations of DMSO averaged at 552.5 ppb with a SD 
of 346.5. Endogenous concentrations of DMS02 in 18 dogs averaged at 70.4 ppm with a 
SD of 50.4. 
In terms of distinguishing between normal DMSO/DMS02 urine levels and dosed 
DMSO/DMS02 urine levels , GC/MS techniques can detect presence of both DMSO and 
DMS02 in all of the blank urine samples and dosed urine samples analyzed. At 200 ul 
per dog dose level , dosed DMS02 levels of two dogs can not be easily distinguished from 
normal DMS02 levels; dosed DMSO levels of dog #8180 were also within the 2 SD 
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range of normal DMSO levels. However, at same dosage, not all of dosed DMSO levels 
of dog #9577 were within the 2 SD range of endogenous DMSO levels. At 1 ml per dog 
dose level, normal DMSO levels were easily distinguished from dosed DMSO levels for 
24 hours post dose time; normal DMS02 levels also can be distinguished from dosed 
DMS02 levels for 24 hours post dose. 
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SECTION II. HYDROCORTISONE 
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INTRODUCTION 
Hydrocortisone is a endogenous steroid compound occurring in man and animal . 
As well as having a potent anti-inflammatory effects, the cortisol also has potent effects 
on protein and carbohydrate metabolism. In man and animal, cortisol is often used 
clinically as an anti-inflammatory agent. In the racing community, exogenous 
administration of cortisol and its syntheti c analogous can be used to affect the 
performance of the racing animals. Because of this , very sensitive and selective methods 
are necessary to establish endogenous corti sol levels in biological samples. 
Among today's variety of analytical technology, GC/MS is usually regarded as 
one of the best confirmation methods for drug detection in racing chemistry. Newly 
developed immunoassay techniques also offer advantages of ease of perform, and 
rapidity, sensitivity and specificity. 
The objective of this study was to investigate urinary threshold levels of 
hydrocortisone in the dog. The work consisted of several stages. T he first part of this 
research work was to determine the characteri stics of different analytical methods such as 
detection ranges, specificity, reliability , precision and accuracy, The second part of this 
work was to focus on the determination of urinary endogenous values of cortisol in the 
greyhound using the optimum method of choice. 
96 
LITERATURE REVIEW 
General Characteristics and Pharmaceutical Effects 
Hydrocortisone (l l,B,17a,21-trihydroxy-4-pregnene-3 ,20-dione, cortisol or 
compound F) is the primary glucocorticoid secreted by the canine adrenal cortex to limit 
the body's response to stress and regulate protein and carbohydrate metabolism. It is 
synthesized originally from cholesterol by a series of reactions. Its molecular weight is 
362.47. UV max is 242 nm (Baxter and Rousseau , 1979). 
Cortisol and its synthetic analogous--prednisolone, methylprednisolone 
dexamethasone, betamethasone, triamcinolone, and paramethasone are known to exhibit 
many important physiological and biochemical effects. In humans, cortisol has been used 
clinically since the early 1950's as an anti-inflammatory agent. In dogs , the 
corticosteroids are used for a variety of conditions. Examples of these are, arthritis, 
dermatitis, eczema, and ocular inflammations (Egan et al., 1977). 
The pharmacological use of cortisol in man and animal has been summarized as 
follows: 
(1) anti-inflammatory uses 
(2) uses in skin diseases 
(3) uses in infectious conditions 
(4) uses in arthritics 
(5) uses in shock 
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(6) uses in immunology. 
The precise mechanism of the anti-inflammatory effects of the corticosteroids is 
not known, but certain characteristics of this action can be enumerated. It produces its 
anti-inflammatory effect by inhibiting vasodilation, by decreasing capillary permeability , 
by modifying the activity of the white cells, and by affecting the connective tissues 
(Melby, 1977). As well as having a potent anti-inflammatory effect, the cortisol also has 
equally potent effects on protein and carbohydrate metabolism. These two effects appear 
equally important and inseparable. 
Most mammalian species are reported to secrete predominantly cortisol. Many 
investigations of adrenocortical secretion in the dog have shown that the main steroid 
produced is cortisol , followed by corticosterone (Adlin and Channick, 1966). One paper 
showed that in the post-race urine samples of 110 horses, the free cortisol measured by 
enzyme-linked-immunoassay showed a mean concentration of 950 nmol/L and covered a 
wide range from 64-3281 nmol/L. The possible causes of the variability were 
summarized as: (1) breed; (2) variability in the adrenal response to excitement and 
exercise; (3) the effects of vasopressin (antidiuretic hormone) which showed a marked, 
but variable increase during a simulated race day (Irvine et al., 1988). Studies also 
indicated that the large variation in the quantities of corticosteroids secreted by different 
dogs under uniform experimental conditions are possible (Hechter et al., 1955). Several 
studies have been done to determine the serum hydrocortisone values in normal dogs by 
different immunoassay techniques (Richkind and Edqvist, 1973; Becker et al. , 1976; 
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Chen et al., 1978; Peterson et al., 1986) . 
Cortisol secretion varies with time of day in many species. Diurnal variation in 
urine or plasma levels in different species have been reported by several researchers. In 
human, plasma cortisol is highest in early morning and lowest near midnight. In equine 
and canine, cortisol plasma levels were high in the morning and low in the evening 
(Harwood and Mason, 1956; Zolovick et al., 1966; Hoffsis et al., 1970a; Larsson et al., 
1979). In nocturnal animals such as the rat, plasma cortisol concentration secretion may 
depend on the sleep-wake or light-dark transition of the subject (Bush, 1953). In Beagles 
and Greyhounds, one paper indicated that there was no diurnal variation of peripheral 
plasma levels of corticosteroids (Richkind and Edqvist, 1973). 
As previously mentioned, cortisol and its synthetic analogues have been used both 
locally and systemically as anti-inflammatory agents and antiarthritic drugs since the 
1950's. When administered to racing animals systemically , however, the corticosteriods 
have a number of pharmacological effects that might be considered useful in improving 
the performance of a racing animal. These agents may improve a racing animal's 
performance through reduction of inflammation, relief of stress, an increase in the 
availability of glucose, and possibly because of the euphoria which is often induced . The 
agents stimulate the utilization of fat and amino acids and thereby increase blood glucose 
levels, which glucose is then available as extra energy for the animal (Tobin, 1981). 
The glucocorticoids also stimulate the appetite and produce an elevation of 
"mood". These actions make cortisol useful in racing animals that are under severe stress 
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and are probably have led to the use of this drug in illegal medicine (Tobin , 1981). One 
study reported the influence of synthetic corticosteroids on racing performance by 
concluding that the synthetic corticosteroids have the potential to change the racing 
performance of horses. Race horses medicated inconsistently with synthetic 
corticosteriods, from one start to the next, tend to have an inconsistent racing form in 
over half of the cases (Watrin, 1988). 
Metabolism and Elimination 
In plasma, usually around 95 % of the cortisol present in the circulation is bound 
to plasma protein. Most of this binding (77%) is to a specific corticosteroid-binding 
globulin (CBG or transcortin) and a lesser amount ( 15 % ) is to albumin, with about 8 % in 
an unbound form . This circulating steroid is largely inactivated in the liver upon 
conjugation with glucuronic acid and sulfuric acid (Tietz, 1970). 
The liver is the important site of catabolism of steroids, and the enzymes 
concerned are located in the sub-cellular fractions. Five major routes exist for cortisol 
metabolism: (1) reduction of the 4-5 double bond , hydroxylation of the 3-keto group; (2) 
hydroxylation at the C2; (3) conversion of the 11-hydroxyl to a 11-keto group; (4) 
reduction of carbonyl group at C20 to two isometric alcohols; (5) hydroxylation at C6 
(Baxter and Rousseau, 1979). 
The major pathways of cortisol metabolism in man are illustrated in Figure 1. 
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Figure 1. The major path ways of cortisol metabolism in man (Baxter and 
Rousseau, 1979) 
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Extra-hepatic catabolism of glucocorticosteroids has been reported to occur in the lung 
(Sowell et al., 1971), skin (Hsia and Hao, 1966), eyes, pituitary (Brown et al., 1957) and 
kidney (Ganis et al. , 1971). 
Excretion is the end compartment of a process that starts with biosynthesis or 
administration and continues through absorption, distribution and metabolism in the 
various body tissues. The different end products of steroid catabolism are usually made 
more water-soluble by conjugation with polar acidic substances before they are eliminated 
from the organism. A small proportion (I%) of ci rculating blood cortisol is excreted in 
the urine in the unconjugated or free state. The excretion of free cortisol in the urine is 
remarkably limited by plasma protein binding which lessens corti sol filtration at the 
glomerulus, and also by the tubular reabsorption of filtered cortisol (Beisel et al. 1964; 
Scurry and Shear, 1969), and this fraction increases or decreases in accordance with 
adrenal output. 
Cortisol is rather rapidly removed from the circulation , having a plasma half-life 
of approximately 60 minutes in humans. Endogenous steroids and their synthetic 
analogues are excreted, almost completely, in both urine and feces mainly as the 
conjugates and in small amounts as free steroids. Steroids metabolites excreted in the 
feces can arise from the unabsorbed drug after oral administration or from their biliary 
secretion . After biliary secretion into the intestine, steroids can be reabsorbed and pass 
into systemic circulation (Hyde and Will iams, 1957). 
The route of excretion of glucocorsteroids varies with the nature of the steroids 
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and the species. In humans, the major proportion of the metabolites of endogenous 
cortisol are excreted in urine as conjugates of glucuronic acid and a minor proportion as 
sulphoconjugates (Kernel and Saito, 1975). The latter are mainly eliminated in the feces 
(Hellstrom et al. , 1969). The majority of the urinary metabolites (50-55%) were 
conjugated with glucuronic acid, about 13- 15 % appeared as unconjugated materials and 
less than 10% was found in the sulphate fraction. In dogs , after administration of 14C-
corticosterone, 55 % of the metabolites are excreted in urine, 32 % in feces. The cortisol 
analogous have longer plasma half lives (Baxter and Rousseau , 1979). 
In animals, some experiments have been done to demonstrate the response of the 
cortisol secretion to age, sex, pregnancy, diet, and exercise. In equine, one study 
indicated that there were no significant differences in the mean plasma cortisol level 
according to age, sex, and pregnancy (Hoff sis et al., l 970a). Ralston et al. ( 1988) studied 
the concentrations of cortisol in blood and urine samples taken from horses after racing. 
They concluded that the sex of the horse had no significant effect on the plasma cortisol 
levels. Urine volume and pH had no significant influence on the urinary cortisol 
concentration, however 9.5% of the urinary cortisol variation could be explained due to 
the influence of plasma cortisol concentration. 
Another study has demonstrated responses of blood cortisol concentration to 
common equine diets. In equine, blood cortisol concentration showed no meal-related 
responses to any of the equine diets within its expected circadian rhythm (Stull and 
Rodiek, 1988). In canine, studies showed that there were no marked differences due to 
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age, sex, body weight, or breed in the blood hydrocortisone values by radioimmunoassay 
(Murphy, 1967; Siegel, 1968; Campbell and Watts, 1973; Chen et al., 1978). 
Cortisol levels can increase in normal animals due to stress, or be very low in 
normal resting animals (Siegel, 1968; Campbell and Watts , 1973; Becker et al., 1976; 
Ling et al., 1979; Feldman , 1985). Aging effects on canine adrenocortical response to 
exogenous adrenocorticotropic hormone (ACTH) were also investigated by fluorometric 
measurement of plasma corticosteroids. Statistical analyses failed to reveal significant sex 
or age differences between samples (Breznock and McQueen , 1970). In man and animals, 
exercise seems to increase the rate of uptake of cortisol. When the work load exceeds a 
critical level, stimulation of the adrenal cortex results in a massive secretion of cortisol 
which is sufficient to raise the plasma level (Few, 1974; Foss et al., 1971). 
Plasma cortisol concentrations in dogs were significantly depressed given either 
dose of dexamethasone or dexamethasone sodium phosphate by posttreatment hour two 
and concentrations remained suppressed for at least 16 hours (Kemppainen et al., 1989) . 
When ACTH (adrenocorticotrophic hormone) was administered, a significant 
increase of the plasma cortisol level was observed 60 to 90 minutes after the injections 
(Richkind and Edqvist, 1973) . The administration of ACTH caused relatively uniform 
increased excretion of urinary cortisol in normal dogs of different ages, breeds, and body 
weights were also reported (Siegel, 1968; Rij nberk et al., 1968). In horses, 
dexamethasone has a half life of 53 minutes whereas prednisolone has a half life of 99.5 
minutes (Toutain et al., 1984). 
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In dogs, the mean exogenous cortisol half life was evaluated to be 52± 1.2 
minutes (Eik-Nes et al., 1953). It was reported that the half life of exogenous cortisol in 
a given dog was not very consistent from one day to another. Errors in timing of sample 
collections, or in the method itself, might account for the disparity (Kuipers et al., 1958). 
In rats , distribution patterns of injected cortisol have been reported. After 5 
minutes almost 50% of the administered Cortisol-4-C 14 was found in the skeletal muscle. 
The total plasma contained only about 7% of the injected dose. It was rapidly released 
through the liver into excretory pathways so that 60 minutes after injection only 2 % 
remained in the muscular tissue whereas 87 % of the material injected was found in the 
gastrointestinal tract. The urine contained only 11 % (Firschein et al., 1957) . 
In horses , the biological half life of cortisol was estimated to be 2.1 ±0.6 hours . 
The disappearance of cortisol was found to be biphasic, composed of redistribution and 
elimination phases. A redistribution phase occurred between 0 and 30 minutes. This 
phase represented the rapid loss of free and bound cortisol from the blood, followed by 
cortisol coming into the blood from tissue reservoirs between 0 .5 and 2 hours. The 
second phase (elimination) occurred between 2 and 12 hours. It was a progressive linear 
decrease to nondetectable or near nondetectable values (Slone et al; 1983). 
Because of potential effect of corticosteroids on racing animals, many racing 
jurisdictions in the United States have rules prohibiting the exogenous use of cortisol and 
other synthetic corticosteroids. Since hydrocortisone is produced naturally by the body, it 
is difficult to determine whether additional amounts have been given to the animal 
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athletes, especially since the normal amounts of cortisol in urine have not been 
determined. 
Analytical Consideration 
Many research papers have been published about the detection of cortisol and its 
metabolites in biological samples using a variety of methods, including thin layer 
chromatography (TLC), gas chromatography with mass spectrometry detection (GC/MS), 
high performance liquid chromatography (HPLC), and immunoassay techniques. 
Sample preparation 
For analysis of steroids in biological sample , the first step of the analytical 
procedure usually should be hydrolysis, either acid or enzyme hydrolysis , a method 
which split (hydrolysis) such ether and ester linkages between glucuronic or sulfuric acid 
and cortisol , enabling the analysis of both free and conjugated cortisol. However, in this 
study, only free state of urinary cortisol level wi ll be analyzed. So, the hydrolysis 
procedure will be omitted. 
The second step is extraction of steroids. In this step, the selection of the organic 
solvent is based on the polarity of the steroid hormones in question. Cortisol and its 
metabolites are steroids with a common 4-ring system and with three or more oxygens. 
They are quite polar, and extract best with solvents such as chloroform, dichloromethane, 
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or ethyl acetate. To improve recovery of compounds, the extraction process is repeated 
three times. The combined extract is blown down to dryness under nitrogen and 
redissolved for further analysis (Tietz, 1970). 
Solid phase extraction of cortisol has also been reported, involving a partitioning 
of compounds between a stationary phase and a mobile phase. The extracted compound 
has a stronger affinity for the solid phase than the sample matrix, yet can be easily 
removed from the stationary phase with a small volume of solvent. For hydrocortisone, 
several solid phase extraction methods have been reported (Shackleton and Whitney, 
1980; Schoneshofer et al., 1980; Diamandis and D'costa, 1988; Park et al., 1990). Of 
these, the sep-pak C18 cartridges are most widely used for rapid sample preparation prior 
to quantitation. This technique is convenient, faster, and results in better recovery of 
analytes. But the following disadvantages still exist in this and all other solid-phase 
techniques: (1) complex elution sequences are not practicable, (2) the relatively expensive 
cartridges are generally used once, (3) each new cartridge has to be activated prior to 
extraction (Dhar and Schoneshofer, 1987). 
Thin layer chromatography 
Thin layer chromatography has been regarded traditionally as a screening method. 
Screening methods are fairly rapid, less sensitive, and contain a lower degree of 
accuracy. Jn terms of cortisol analysis, TLC can be used as an acceptable screening 
method for initial separation, tentative identification, and visual semiquantitation . Jn the 
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literature, the reported detection limit of cortisol, employing silica gel G TLC was 1.2 µg 
with carbazole-sulfuric acid spray reagent (Ghosh and Thakur, 1982). 
Gas liquid chromatography 
In most forensic laboratories, gas liquid chromatography usually be used for drug 
confirmation by utilizing various detection methods, such as FID, ECD, or mass 
spectrometric detection. Of the three, GC/MS remains one of the most commonly used 
confirmation method . 
The integration of gas chromatography wi th mass spectrometry also made possible 
the analysis of steroids in the low nanogram range and resulted in the most powerful 
technique available for structural elucidation of steroids in biological samples. 
There were four reports in the literature about the detection of hydrocortisone by 
gas chromatography mass spectrometry using glass capillary columns (Singh, 1989; 
Ralston et al. , 1990; Ulick et al. , 199 1) . One report cited use of a packed column 
(Lantto, 1982). 
However, analyses of corticosteroids by GC/MS methods, while highly sensitive 
and specific, require derivatization prior to injection because the compounds are 
thermally instable and their volatility is low for direct GC and GC/ MS analysis. Some 
chemical derivation methods are usually needed to convert the corti sol to thermally stable 
compound. 0-methyloxime-trimethylsilyl ether derivatives of cortisol and its metabolites 
have been used prepared before GC injection (Lantto , 1982; Singh, 1989; Ralston et al., 
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1990; Ulick et al., 1991). In general , the ions present at m/e 73 and m/e 75 in the mass 
spectra of most steroids TMS derivatives are formed by fragmentation of the trimethyl-
silyl groups and carry a high ion current relative to the other ions in the spectrum yet 
yield virtually no structural information . Various other important chromatographic 
parameters for cortisol are listed in Table 1. 
Compared to other chemistry methods , however, gas chromatography cortisol 
assays always involve lengthy sample preparation/extraction/derivatization procedures. 
Moreover, elevated-temperature separation may decompose some drug molecules. In 
addition, the successive derivati zation procedures can form multiple products due to 
incomplete reactions which in turn produce mass spectra with low abundance molecular 
ions and fragmentation patterns that are dominated by the type of derivative rather than 
the drug 's structure (Houghton et al., 1981). 
Hi2h performance liquid chromatoeraphy 
HPLC with UV detector procedure was reported for detection of synthetic and 
natural corticosteroids in biological fluids. Because there is no possibility of thermal 
decomposition, HPLC offers the advantage that the corticosteroids can be analyzed 
without derivation. HPLC interfaced to a mass spectrometer offers the further advantage 
of a highly specific detection of steroids in biological ex tracts. All corticosteriods show 
the Emax of 246 nm based on the A4-3-keto group (Park et al., 1990). Other LC 
Table 1. Operating conditions and detection limits of hydrocortisone concentrations measured by gas liquid 
chromatography using mass spectrometric detection. 
ARTICLE COLUMN OVEN TEMP. CARRIER GAS DETECTION LIMIT 
Lantto, 1982 1.5 m x 2 mm l.D. 250 °c Helium NA 
Singh, 1989 not given 280 °c Helium NA 
Ulick~ al., 1991 30 m x .25 mm l.D. 280 °c Helium NA 
Ralston~ al., 1990 30 m x .25 mm l.D. 310 °C Helium NA 
NA mean not given 
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detection procedures have also been reported for steroid analysis. Included are (1) by 
using derivatization reaction with fluorescent compounds (Seki and Yamaguchi, 1983; 
Nozaki et al., 1991 ; Haegele and Wade, 1991), (2) by using high performance liquid 
affinity chromatography (Nilsson, 1983), (3) by using LC/ MS techniques which offers the 
further advantage of highly specific detection of these steroids in biological sample 
(Skrabalak et al., 1984; Park et al., 1990). 
There are two possible liquid chromatography methods fo r the separation of 
cortisol in biological samples: normal phase HPLC (Cavina et al. , 1973; Sayegh and 
Vestergaard, 1978; Rose et al. , 1979; Schoneshofer et al. , 1980b; Nakamura and Yakata, 
1985; Haegele and Wade, 1991), and reversed phase HPLC (Okumura, 1981; Lantto, 
1982; Seki and Yamaguchi, 1983; Skrabalak et al., 1984; Ralston et al., 1988; 
Diamandis and D'costa, 1988; Nozaki et al. , 1991 ; Park et al. , 1990; Shalaby and 
Shahjahan, 1991; Wade and Haegele, 1991). 
In reverse phase chromatography, a non-polar stationary phase, such as silica gel, 
chemically bonded with a C18 chain or other organic functional groups, and a polar 
mobile phase, such as acetonitrile or methanol/water, are used. The organic analytes 
interact with the stationary alkyl chains. In normal phase chromatography, a polar 
stationary phase, such as of silica gel , and a non-polar mobile phase, such as methanol or 
acetonitrile, are employed. Separation is due to the interaction between the "active" 
silanol groups and the analytes. Normal phase is very useful in resolving structurally 
similar molecules. Various other chromatographic parameters and the detection limits for 
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the analysis of cortisol are listed in Table 2. 
High performance liquid chromatography can detect cortisol levels in the low 
nanogram range (Schoneshofer et al., 1980; Nakamura and Yakata, 1985; Rose and 
Jusko, 1979; Park et al. , 1990; Park et al., 1990; Wade and Haegele., 1991). The major 
disadvantages indicated by some authors were that HPLC method is time consuming, and 
it requires large sample volumes. 
Fluorometric analysis 
Free cortisol can be measured by fluorometric techniques in the presence of 
sulfuric acid (Breznock and McQueen , 1970; Ratliff and Hall , 1973). Fluorometric 
methods also exhibit some drawbacks. Since cortisol is a small molecule, it is structurally 
similar to many steroids found in biological fluids , and it is present in low concentration 
(ppb) in body fluids, so fluorometric techniques often overestimate the true amount of 
cortisol present. These methods also have been reported to show poor reproducibility 
(Frankel et al., 1966). 
Immunoassay techniques 
All the immunoassay are based upon the selective reactivity of an antigen to an 
antibody which has been raised to that antigen . All formats utilize a detectable tag such as 
an enzyme, a fluorophore or radioisotope which is attached to either the antigen supplied 
with the test or attached to antibody provided with the test. All immunoassay measure the 
Table 2. Operating conditions and detection limits of hydrocortisone concentrations measured by high 
performance liquid chromatography. 
ARTICLE COLUMN 
Lantto, 1982 not given 
Nucleosil-N02, Supelco 
Park et fil. , 1990 100 x 4.6 mm I.D. 
Hypersil-ODC 
Schoneshofer et fil., 1980 250 x 3 mm I.D. 
Diol-sil , Merck 
Ralston ~ fil. , 1988 25 x .46 mm l.D. 
C18 
Wade and Haegele, 1991 250 x 2 mm I.D. 
Keystone-CS 
Rose and William, 1979 250 x 4.6 mm l.D. 
Zorbax-sil , DuPont 
MOBILE PHASE 
DCM/ethanol 
(97:3) 
H20/acetonitrile 
n-hexane/i-propanol 
(75:25) 
H20/acetonitrile 
(40:60) 
Acetonitrile/methanol 
/water (10:40:50) 
methanol/methylene 
chloride (3:97) 
DETECTOR 
TYPE 
UV 254 nm 
Diode array 
UV 246 nm 
UV 254 nm 
UV 245 nm 
UV 240 nm 
UV 254 nm 
DETECTION 
LIMIT 
not given 
10 ng/ml 
4.9 pg 
not given 
0.5 ng /ml 
15 ng 
--N 
Table 2. (continued) 
ARTICLE 
Cavina et .fil. , 1973 
COLUMN 
300 x 2 mm I.D. 
Silicic-acid, Bio-Rad 
Diamandis and D'Costa, 1988 300 x 3.9 mm I.D. 
Bondapa.k-C 18, Waters 
Nilsson, 1983 250 x 5 mm l.D. 
Lichrosorb RP-18 
Nakamura and Ya.kata, 1985 250 x 4.6 mm I.D. 
Zorbax-CN, DuPont 
Shalaby and Shahjahan, 1991 150 x 4.6 mm l.D. 
UI trasphere-ODS 
MOBILE PHASE DETECTOR DETECTION 
TYPE LIMIT 
methanol/chloroform UV 240 nm not given 
tetrahydrofuran/methanol UV 254 nm not given --~ 
/water 
methanol/water (60:40) UV 254 nm not given 
methanol/water (40:60) UV 242 nm 40 ng 
acetonitrile/phosphate UV 250 nm not given 
buffer (6:4) 
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concentration of tag present after natural sample antigen has an opportunity to react with 
kit antigen and/or antibody. The amount of tag detected at the end of a test is correlated 
to natural antigen present initially in the sample. The immunoassay techniques are usually 
sensitive, simple, rapid , and inexpensive methods for chemical analysis including 
corticosteroids. Several formats of immunoassay are employed in drug detection , such as 
radioimmunoassay (RIA) , enzyme immunoassay (EIA), fluorescence polarization 
immunoassay (FPIA), enzyme-linked immunosorbent assay (ELISA), etc. 
In RIA, a "specific" antibody to a drug molecule is used to bind both a sample of 
radiolabeled drug and whatever unlabeled drug may be added with the unknown plasma 
or urine sample. The basic principle of RIA is outlined as follows: 
where 
L * + L + Ab = Lab + L *Ab + L * + L 
L * = the radio labeled ligand or bound tracer, 
L = the unlabeled ligand, or the drug molecules, 
Ab= the antibody. 
In the presence of limited binding sites of the antibody, L* and L undergo 
competitive binding. After reaching equilibrium at the end of the incubation period, L 
and L* will form Lab and L*Ab, the " antibody-bound" fraction, while the remaining L 
and L * will remain as the "free" fraction. The bound and free fraction are separated and 
the radioactivity of the bound portion is measured. If a significant amount of 
nonradioactive drug is added to the system, enough drug is displaced for the reduction of 
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radioactivity in the system to be measurable. The quantity of drug present in the original 
sample will be inversely related to the amount of radioactivity measured. The radioactive 
tracer used to compete with the unlabeled drug can be either 1251, 3H, or 14C, 75Se, 
etc. 
In the literature, there were numerous reports about cortisol analysis using RIA 
technique (Hasler et al., 1976; Chen et al., 1978; Johnston and Mather, 1978; 
Schoneshofer et al., 1980b; Lantto, 1982; Peterson et al., 1986; Ralston et al. , 1988). 
The reported lowest detection limit for cortisol was 10 pg (Chen et al., 1978). Method 
selectivity or degree of cross reactivity varied according to the an tibody which was being 
used. 
Other immunoassay techniques are al so available for the analysis of cortisol. 
Included are: Enzyme-immunoassay analysis (EIA). Its principle is si milar to RIA ' s 
except that the steroids (the antigens) compete with an enzyme labeled analog for the 
antibodies against the antigen being analyzed. There were several schemes of the enzyme 
immunoassay for the analysis of cortisol reported (Pearson et al. , 1981; Markina et al. , 
1989; Karaseva et al. , 1990) , each of which has its advan tages and drawbacks. 
Peroxidase, /3-galactosidase, or dehydrogenase are most often used as the marker 
enzymes of cortisol. 
A competitive protein-binding (radiotransinassay RTA) method was also being 
used for cortisol measurement (Hoffsis et al, 1970a; Fiorelli et al. , 1972; Peterson et al., 
1986; Pearson et al., 1981) . Cortisol competes with a radioactive labeled tracer for 
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binding sites on indigenous plasma proteins or "transins" (e.g., transcortin, globulin). 
The bound portion remains in the aqueous phase while the displaced tracer passes into the 
scintillator phase, where its radioactivity is counted. The lowest detection limit was 
reported as 100 pg (Pearson et al., 1981). 
A fluorescence polarization immunoassay (FPIA) was employed in the present 
studies. If a small fluorescent antigen with rapid movement becomes bound to an 
antibody, rotational relaxation time will be increased as a result of formation of the 
antigen-antibody complex with slow movement. Thus the polarization is increased. When 
an unlabeled antigen is added to this system, it competes with fluorescent antigen for 
binding to the antibody and the amount of free fluorescent antigen with rapid movement 
is increased. Thus the rotational relaxation time is decreased and the polarization 
decreased. If the amount of antibody is constant, the degree of polarization will be 
inversely correlated with the amount of added unlabeled antigen. In other words, the 
added unlabeled antigen can be determined from the degree of decreased polarization 
(Ngo, 1988). However, these methods all have the disadvantages of the synthesis of 
either radiolabeled or enzyme labeled cortisol tracers, cross reactivity, as well as the 
possibility of radioactive contamination. 
Enzyme-linked immunosorbent assay (ELISA) is a newer immunoassay technique 
available for cortisol screening test (Lewis and Elder, 1985; Irvine et al., 1988; Ford et 
al., 1990). When cortisol (when present in the sample) binds to a cortisol antibody in a 
plate, which is washed after formation of the antibody-cortisol complex. Antibody 
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specific for a different site on the cortisol is then added, and is again washed. This 
second antibody is attached to an enzyme such as alkaline phosphatase or peroxidase. 
This enzyme can rapidly convert an added colorless substrate into a colored product 
which can be detected by a colorimetric procedure. Substrate conversion is monitored by 
absorbance change at a UV wavelength appropriate for different substrates. The amount 
of second antibody bound to the plate is proportional to the quantity of cortisol in the 
sample. This method is superior to RIA in terms of expense, time, simplicity, and 
instrumentation. It does not require handling of radioactive material. 
The major drawback of various immunoassay techniques is that antibodies 
partially cross-react with endogenous cortisol as well as synthetic steroids. These 
techniques cannot unequivocally distinguish similar synthetic or endogenous 
corticosteroids and false determinations are frequently encountered. One report by 
Pearson and his colleagues (1981) showed that some of the immunoassay methods (RIA; 
RTA with four different antibodies and three transins) used for cortisol detection without 
chromatography grossly overestimate the amount of cortisol in urine. Schoneshofer et al. 
(1980a,b) made a similar discovery. Specific estimation urinary cortisol by 
radioimmunoassay requires a preceding chromatographic technique of high efficiency, 
such as HPLC or GC/MS . 
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Comparative studies 
In the literature, various investigators have analyzed the capability of numerous 
procedures to detect cortisol presence on an individual basis. In addition, there has been a 
comparison study between the competitive protein-binding assay vs. radioimmunoassay 
for plasma cortisol detection (Peterson et al., 1986). The author indicates that there was 
excellent correlation between the cortisol values obtained by the two assay methods. The 
detection limit of both the competitive protein-binding assay and the RIA was 1.0 ng/ml. 
Lantto (1982) has reported the compared results by three different routine methods for 
analysis of free urinary cortisol: (1) isotope dilution-mass spectrometry (ID-MS); (2) 
HPLC; (3) two radioimmunoassay methods, one involving direct assay and one involving 
extraction . 
The results indicated that the HPLC method turned out to be the most nearly 
accurate of the different routine methods tested (regression coefficient 0 . 86); ID-MS gave 
less accurate results. Further purification did not change the results obtained. Two RIA 
methods gave considerably higher values than those achieved with the comparison 
method. Extracting the samples before analysis did not improve the accuracy. 
A comparison study of HPLC with a diode array detector vs. thermospray LC/MS 
techniques for analysis of corticosteroids in urine was also reported by Park et al.(1990). 
Their results indicated that HPLC allows the simultaneous determination of at least ten 
corticosteroids with a simple, reproducible, and reliable analytical procedure. Detection 
limit by diode array detector (DAD) was 10 ng/ml in 5 ml of urine. It seems to indicate 
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that the thermospray LC/MS technique produced useful information concerning the 
molecule weight of corticosteroids without the need for derivatization and could give a 
lower detection limit 10 to 50 ng in the scan mode and 1 to 5 ng in SIM mode. Their 
results also indicated that the extraction recovery of each corticosteroid from the spiked 
urine by liquid-liquid extraction at pH 9 using diethyl ether was greater (85 % ) than the 
result obtained by solid-phase extraction with a sep-pak C18 cartridge (79%). 
Singh (1989) reported comparison results of electron impact vs. chemical 
ionization gas chromatography-mass spectrometry for screening of steroids in horse urine. 
His results revealed that chemical ionization mass spectrometry was more sensitive than 
the electron impact ionization mass spectrometry for cortisol analysis. The extraction 
efficiency by liquid-liquid used in this study without TLC clean-up was approximately 60-
70% from urine and reduced to 45-55 % with TLC clean-up. 
In addition, a comparison of the quantitation of urinary free cortisol from post 
race thoroughbred standardbred horses has been made using radioimmunoassay (RIA) and 
gas chromatography mass spectrometry (GC/MS) (Ralston et al., 1990). Their results 
showed that there was a good correlation between the absolute urinary cortisol values 
obtained by GC/MS and the values obtained by RIA. As such, the cortisol RIA method 
did appear to be an acceptable quantitative screening method for cortisol in urine. 
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EXPERIMENTAL 
Materials and Instrumentation 
Gas chromatoeraphy and mass spectrometer 
Hewlett Packard model 5890 gas chromatography connected to Hewlett Packard 
5988A quadrapole mass spectrometer-data station equipped for electron ionization with 
positive ion collection was used for mass spectral colleclion . All GC/MS analysis were 
performed using a DB-5 capillary column , 15 m x 0 .25 mm fused with 0.25 µm film 
thickness, purchased from J&W Scientific, Rancho Cordova, CA . 
TDx FLx (FPIA) immunoassay 
The fluorimeter used for quanti tating fluorescence polarization immunoassay is 
commercialized by Abbott laboratories (North Chicago,IL). It can measure automatically 
polarization components and compute a polarization value after correcting for background 
and optical bias. The TDx FLx cortisol kits were also purchased from Abbott 
Laboratories. Only the reagents supplied in the respective kit were used in the analyses. 
Systems cuvettes (No.9518-06) , tri-well sample cartridges (No.9560-05) , carousels 
(No.9518-11) and TDx FLx analyzer (No.9520-XX) were provided by Abbott 
Laboratories, (North Chicago, IL). 
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Materials and supplies 
All organic solvents used in this study were Fisher HPLC grade or equivalent and 
chemicals/reagents used were reagent grade or better. Most chemicals and reagents were 
purchased from Fisher Scientific (Fair Lawn, NJ) including: ethyl acetate, methanol, 
acetone, acetonitrile, sodium borate, chloroform, potassium permanganate, ethanol, and 
concentrated sulfuric acid. 
Hexamethyldisilazine (HMDS) and pyridine for silanization for glassware were 
acquired from Pierce Chemicals Company (Rockford, IL) and Aldrich Chemical 
Company, Inc. (Milwaukee, WI) respectively. 
Pipemen precision microliter pipettes, utilized in all procedures for liquid 
dispensation were purchased from Rainin Instrument Company, Inc. (Woburn, MA). 
Hydrocortisone standard used for standard and spike preparations was obtained 
from Sigma Chemical Company, Inc. (St. Louis, MO). Screw top test tubes (16 x 
125mm) with PTFE lined caps used in the liquid-liquid extraction steps were purchased 
from Fisher Scientific, (Fair Lawn, NJ) . Thin layer chromatography separations were 
performed on Kiesel silica gel 60 plates with F254 fluorescence indicator purchased from 
EM Science, (Gibbstown, NJ). 
Hydrocortisone sodium succinate was obtained from the Upjohn Company 
(Kalamazoo, MI.) Graduated wide mouth specimen containers for initial urine collection 
and final storage were purchased from Cole-Parmer Instrument Company, Inc. (Chicago, 
IL) . 
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Drug Administration and Sample Collection 
Blank urine collection for hydrocortisone threshold analysis 
a. Five dogs,# 8445, # 9494, # 9485, # 9487, and# 9491, weighed from 20-25 
kg. Urine samples were collected from each dog at 10:00 a .m. every morning 
consistently for five days. 
b. Three dogs, # 8445, # 9494, and # 9485, weighed approximately from 20-
25kg. Urine samples were obtained by cup-on-a-stick volunteer collection at 0 , 2 , 4, 6, 
8, 12, 18, and 24 hour respectively. The samples were capped , labeled, stored at -10 °c 
until analyzed. 
Canine administration and sample collection 
Two retired racing greyhounds, # 9485 and # 9491, weighed approximately 24 kg 
were administrated intravenously via the left front leg, 50 mg hydrocortisone sodium 
succinate. Urine was obtained by cup-on-a-stick volunteer collection before cortisol 
exposure and at regular intervals for several days thereafter. The samples were capped, 
labeled, and stored at -10 °c until analyzed . 
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Analytical Methods 
Liguid-liguid extraction (Cortisol administrated and blank urine) 
A steroid urine (SU) extraction procedure was used in this study to extract 
hydrocortisone out of dog urine (both dosed and blank). 9 ml urine at each collection 
time for both dogs was used when extracting dosed and blank urine for TLC and GC/MS 
analysis. 
After thawing in warm water, 9 ml of urine were added to each of labeled screw 
cap test tubes. One ml of saturated sodium borate solution was added to each tube for 
hydrolysis of urine. Urine were extracted three times with 3.0 ml of ethyl acetate. 
Extracts were combined in a clean tube, 1.0 ml of 15 % sodium sulfate/ LON NaOH was 
added to the extracts, vortexed well , and the organic phase was transferred and 
evaporated to dryness under nitrogen. Residue was dissolved in 50 µl of ethyl acetate, 
capped and vortexed for TLC and GC/MS analysis. For TLC analysis, 5 µl of the final 
extracts were plated on TLC plate. For GC/MS analysis, 1 µl of the final extracts was 
injected into the GC/MS system. 
Liguid-liguid extraction (cortisol spiked urine and water) 
After thawing in warm water, 9 ml of urine or water was spiked at following 
concentrations of hydrocortisone: 10 ppb, 25 ppb , 50 ppb, and 100 ppb. Extraction of 
cortisol spikes was performed using the same extraction procedure previous men tioned . 
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Thin-layer chromatoeraphy techniques 
For hydrocortisone analysis, the extracts were developed on the plate for a 
distance of 5 centimeters from the origin with chloroform:ethyl acetate:methanol 
(50:45:5) . After drying, the plates were developed again with Davidow for a distance of 
7 centimeters from the origin. Following development, plates were visualized under short 
and long wave ultraviolet light for quenching and fluorescence respectively. Lastly, the 
plates were spayed with 50% sulfuric acid : ethanol, heated gently on hot plate until 
standard turns grey. Hydrocortisone reacted to give a yellow color spot on plate under 
LWUV light. 
Gas chromatoeraphic techniques and conditions 
For GC/MS analyses, DB-5 fused silica columns, 15m x 0.25mm with 0.25 µm 
micron loading film thickness were used. Prior MO-TMS derivatization of extract was 
necessary before injection to the GC/MS system. Procedures for MO-TMS derivatization 
were: 
(1) Put 10 ug hydrocortisone into a 2 dram vial. Blew dry under nitrogen. 
(2) Added 50 ul methoxamine in pyridine. Capped tightly. Heat at 80 °c for 30 minutes. 
(3) Evaporated with nitrogen plus heat. (4) Added 50 ul N-methyl-N-TMS-
trifluoroacetamine (MSTFA), Capped and foiled tightly. Derivatized for 2 hours at 80 °c. 
(5) Added 0.5 ml water and 2 ml ether. Vortexed well. (6) dry ether over pipet with 
sodium sulfate into 1 dram vial. (7) Evaporated under nitrogen and heat. (8) Transferred 
to nipple vial with 50 ul acetonitrile. 
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All GC/MS analyses were performed with a Hewlett Packard 5890 A gas 
chromatography connected to a Hewlett Packard 5988 quadrapole MS in electron impact 
ionization, with positive ion collection at 70 e V. 
Conditions for GC/MS were: 
Injector temp. 
Oven temp. 
Carrier gas (Helium). 
Injection mode 
Electron energy 
Source temp. 
265 °c 
Start at 70 °C Hold for 1 minute, 
then programmed at 20 °C per minute to 300 °C. 
1 ml/min flow rate 
Splitless 
70 eV 
250 °c 
TDx FLx fluorescence polarization immunoassay method 
No pretreatment was necessary for urine sample of TDx FLx cortisol assay. Urine 
to be analyzed was added directly to sample cartridge. The cortisol calibrators 
accompanying the kit were used for instrumental calibration and standard preparation. 
Three cortisol control samples were also supplied with the kit. The exact procedure used 
for the kit is listed in the appendix. All reagents utilized in the TDx FLx method were 
supplied by Abbott Laboratories. All working standards were prepared in blank dog urine 
by dilution of hydrocortisone stock solution ( 1 µg/ µ1 hydrocortisone in methanol). The 
excitation and emission wave lengths were 485 nm and 525 to 550 nm, respectively. 
Limit of detection 
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RESULTS AND DISCUSSION 
Classical Techniques 
TLC For cortisol screening on TLC plate, the plate were developed for a 
distance of five centimeters from the origin with chloroform:ethyl acetate:methanol 
(50:45:5). After drying, the plate was developed again with Davidow for a distance of 
seven centimeters from the origin. Following plating and development of hydrocortisone 
standards on the TLC plate, quenching was observed under SWUV. Lastly, the plate was 
sprayed with 50% sulfuric acid:ethanol, heated gently on hot plate until standard turns 
grey, and the spots of interest were then visible on the plate. Rf value of hydrocortisone 
is 0.77. 
Concentrations of 5, 4, 3, 2, 1, 0.5, 0.25, 0.1 , 0.05 , and 0.025 µg of 
hydrocortisone standard present on the TLC plate were developed, visualized under UV 
light, and sprayed with the spray reagent. All concentrations higher than, and including 
0.25 ug , were visible to the naked eye at the Rf value of interest. Below 0.1 µg the 
ability to visualize the spot of interest with the naked eye was very difficult. When taken 
into context that an actual TLC plate would contain a large number of samples, each with 
endogenous consistent becoming visible following spraying, the detection limit of 
hydrocortisone would have to be classified as approximately 0.25 µg on the TLC plate. 
Figure 2 shows the typical results of cortisol standards on TLC plate. 
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GC/MS For hydrocortisone analysis by GC/MS, some sample preparation and 
derivatization procedures have been studied. No result is available. 
HPLC For hydrocortisone analysis by HPLC. little work has been done. 
No result is available at this point. 
Sample spikes 
Extraction of hydrocortisone aqueous and urine spikes was performed to determine 
if the extraction procedure used were efficient and reproducible. Also, some knowledge 
about matrix effects would be obtained. 
TLC Nine ml of blank dog urine was spiked with hydrocortisone and then 
extracted following the steroid urine extraction procedure. Urine were spiked at following 
concentrations: 0.1 ppm, 0.25 ppm, 0.5 ppm, 1 ppm, 2 ppm, 5 ppm, and 10 ppm. After 
extraction and evaporation, 5 µI out of 50 µI extract were plated on the TLC plate, 
hydrocortisone standard was also spotted on each side of the plate. The plate was then 
developed, visualized and sprayed with proper solvents and reagents. For aqueous spikes, 
all concentrations higher than, including 0.25 ppm were visible to the naked eye. Below 
0.1 ppm the ability to visualize the spot of interest with the naked eye was very difficult. 
For urine spikes, all concentrations higher than, including 0.25 ppm were visible to the 
naked eye. The lowest detectable concentration of hydrocortisone in urine matrix on TLC 
plate would have to be determined as 0.25 ppm. In water matrix, the lowest detectable 
concentration of hydrocortisone on TLC plate would be determined as 0.25 ppm also. 
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Figure 2. Thin-layer chromatographic results of cortisol standard 
Spray sequence = 50% sulfuric acid:ethanol 
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Figure 3. Thin-layer chromatographic results of cortisol spikes following SU 
extraction of 9 ml water 
Spray sequence = 50 % sulfuric acid:ethanol 
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Figure 4. Thin layer chromatographic results of cortisol spikes following 
extraction of 9 ml urine 
Spray sequence = 50% sulfuric acid:ethanol 
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The results indicated that biological matrix has no obvious impact on 
spike recovery. Figure 3, 4 shows the typical results of cortisol water and urine spikes on 
TLC plates. 
Immunoassay Techniques 
The TDx FLx fluorescence polarization immunoassay (FPIA) is a simple, and 
relatively sensitive method for the quantitative analysis of urinary free hydrocortisone 
with or without organic solvent extraction and chromatographic prepurification. The assay 
also can be used to detect conjugated hydrocortisone in urine. The majority of the 
hydrocortisone and its metabolites are excreted in the urine as the water-soluble 
conjugates of glucuronic acid and sulfuric acid. In order to detect conjugated cortisol 
levels in urine by FPIA method,, the splitting (hydrolysis) of such ether and ester 
linkages is an obligatory first step. Following hydrolysis, the free cortisol become 
sparingly soluble in aqueous solution, and then the cortisol assay can be utilized to 
determine cortisol levels. However, like most immunoassay methods, the major drawback 
of FPIA technique is that antibody partially cross-react with endogenous cortisol as well 
as synthetic steroids. So, determination of cross-reactivity of the assay is also an 
important part of this work. 
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Standard curves 
(1) FPIA standard curve in serum was constructed by using the calibrators 
accompanying with the kit as standards, diluted with 0.0 calibrator. The concentrations of 
cortisol calibrators were: 1, 5, 10, 25, 50, 100, 250, and 600 ppb. All the standards were 
analyzed in triplicate. Figure 5 shows a typical standard curve of cortisol in serum. 
(2) FPIA Standard curve in urine was constructed by using stock cortisol standard 
(1 µg/µl), diluted it with blank dog urine as following concentration: 0, 5, 10, 25, 50, 
100, 250, and 500 ppb. All the standards were analyzed in triplicate. Figure 6 shows the 
standard curve of cortisol in urine. 
Sensitivity 
The lowest measurable level is defined as that concentration which can be 
distinguished from zero at the probability < 0.05 significance level. It was determined 
by one group T test to be 5 ppb (P = 0.045) , in serum, and 10 ppb (p = 0.009) in 
urine. This is consistent with the results of the manufacture who reported a detection 
limit of 4.5 ppb in serum. 
Precision 
Table 3 shows the results of assay reproducibility study by the kit manufacturers. 
In our studies, for each batch of samples, two or three of control samples accompanying 
with the kit were included. A four-point standard curve was also included in every day 
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Figure 5. Hydrocortisone standard curve in serum by TDx FLx with error 
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Figure 6. Hydrocortisone standard curve in urine by TDx FLx with error 
bars indicating 2 SD, n = 3 
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Table 3. Statistical analysis of within-run and between-run precision study by TDx kit 
manufacturers. 
Target value Concentration (µg/dl) 
4.0 15.0 40.0 
mean 4.20 14.60 40.44 
SD within run 0.43 0.65 1.16 
CV within run % 10.73 4.35 2.90 
SD between run 0.39 0.75 1.94 
CV between run % 9.73 4.97 4.86 
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analysis. The correlation coefficients were always better than 0.99. All the control 
samples and standards were analyzed in triplicate. CV and SD of daily and day to day 
variation of standards and control samples in our studies are given in Table 4. 
Table 4. Statistical analysis of within-day and day to day precision study by TDx (ours). 
Number of Mean of Cone of 
Analyses Fluor units Standard 
Within-day precision study (standards) 
3 7.72 25 ppb 
3 10.25 50 ppb 
3 16.97 100 ppb 
3 36.92 250 ppb 
Day to day precision study (standards) 
43 9.04 25 ppb 
43 11.75 50 ppb 
43 17.64 100 ppb 
43 36.45 250 ppb 
Day to day precision study (control samples) 
48 
51 
27 
4.52 
15.29 
41.15 
4 µg/dl 
15 µgldl 
40 µgldl 
SD of 
Fluor units 
.58 
.25 
.56 
.85 
1.41 
1.16 
1.34 
2.51 
0.71 
1.29 
2.78 
CV% 
7.48 
2.39 
3.27 
2.29 
15.67 
9.90 
7.64 
6.88 
15.56 
8.43 
6.75 
137 
Results from day to day precision studies typically yield CV's of less than 16 % 
for the low control (4 µg/dl) and the low standards (25 ppb) and less than 10 % for the 
medium and high controls and the high standards (above 25 ppb), which are consistent 
with manufacturer's results which yielded CV's of less than 15 % for the low control and 
less than 9% for both the medium and high controls. 
Determinations of cross-reactivity with various compounds 
Cross-reactivity was tested with endogenous or synthetic steroids whose chemical 
structure could cause interference with the Cortisol assay. Cross-reactivity of a compound 
was determined by assaying it in blank urine at the following concentrations: 10, 25, 50, 
100, 250, and 500 ppb. All the standards were prepared from I µglµI stock standards and 
analyzed in triplicate. Percent cross-reactivity = 100 x (measured concentration of 
cortisol divided by the concentration of the test compound , determined at 500 ppb). 
Table 5 shows the results of cross-reactivity studies in thi s study and the kit 
manufactures. The two sets of results are consistent. The results show that the cross-
reactivity of the cortisol antibodies with triamcinolone is quite high. Figure 7 represents 
the cortisol cross-reactivity curves by FPIA. 
Diurnal variation 
Cortisol concentrations in dog urine may be subject to diurnal variations (daily 
variations). Diurnal variations can lead to cortisol values in dog urine which would be 
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Table 5. FPIA cortisol specificity study (cross-activity) 
STEROID 
Endogenous: 
testosterone 
Synthetic: 
dexamethasone 
betamethasone 
prednisone 
prednisolone 
methyl prednisolone 
Triamcinolone 
Endogenous: 
11-deoxycortisol 
corticosterone 
cortisone 
tetrahydrocortisol 
17-0H-progesterone 
11-deoxycorticosterone 
6-{J-OH-cortisol 
progesterone 
11-{J-OH-progesterone 
{J-cortol 
{J-cortolone 
testosterone 
cortisol-21-glucuronide 
Synthetic: 
prednisolone 
6-methyl prednisolone 
dexamethasone 
prednisone 
Cross-reactivity % by this study 
0.98 
3.39 
2.64 
2.36 
28.46 
13.02 
43 .81 
Cross-reactivity % by kit manufacturers 
4 .7 
4.5 
1.1 
0.8 
0.5 
0.4 
0.2 
0. 1 
0.1 
0.1 
0.1 
0.1 
0.1 
23.8 
1.1 
0.6 
0.4 
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abnormal and have doubtful significance in correlation with cortisol threshold 
determination. Diurnal variation of cortisol in dogs was determined with the urine 
samples from dog # 8445, # 9485 , and # 9494. Urine samples were collected in wide 
mouth containers at eight intervals during a 24 hours military time cycle. (0.00, 
02.00,04.00, 06.00, 08.00, 12.00, 18.00, and 24.00). All the samples were analyzed in 
triplicate, standards and controls were analyzed in duplicate. 
Figure 8 shows the diurnal variation curves of cortisol level of three dogs. In dog 
#9494 (female), cortisol concentration is greater than that at any other given time at 
24.00 hours. At 24.00 hours, the urine cortisol level is 66% greater than at 06.00 hours. 
Dog #9485 (female) , the highest point of cortisol level is at 02.00 hours . The cortisol 
level at 02.00 hours is 60% greater than at 06.00 hour. In dog #8445 (male) , cortisol 
levels do not change significantly throughout 24 hours, there is no significant rise in 
cortisol levels during 24 hours. For all three dogs, the lowest urine cortisol level is at 
8.00 hours. It can be concluded that in two female dogs, cortisol urinary levels are the 
highest in the early or late morning hours and lowest in the afternoon . 
There was no publication in the literature about diurnal variation pattern in dog 
urine. The absence of diurnal variation of peripheral plasma levels of corticosteroids was 
previously reported by Breznock and McQueen (1970) and Richkind and Edqvist(I973). 
However, in the dog, one study showed that total glucocorticosteroid levels were highest 
in morning hours (09.00 hours) in plasma (Harwood and Mason, 1956) . Several 
researchers indicated that cortisol levels can increase in normal animals due to a number 
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of different stimulus such as environmental changing, stress or due to a fact that dogs be 
frightened during the experiment (Siegel, 1968; Becker et al., 1976; Feldman, 1985). 
Endogenous and Dosed Drug Concentrations 
The normal concentrations of cortisol in research doe urine 
Initially the normal concentration of urinary cortisol and its day to day variation 
were determined in the five research dogs(# 8445, # 9494, # 9485, # 9487, and# 9491) 
during a four days period by urine sampling at 9.00 to 10.00 a.m every day. Day to day 
variation curves of cortisol levels of five dogs are shown in Figure 9. 
For each batch of samples, two controls were included, the controls were placed 
in the first and last position in the carousel. A four-point standard curve was constructed 
every day. All the standards and controls were analyzed in duplicate, all the samples 
were analyzed in triplicate. No day to day variation pattern of cortisol level was obtained 
from this work. The normal hydrocortisone concentrations in five dogs varied from 46.32 
to 179.39 ppb, with a mean concentration of 101.8 ppb (SD = 37.1). Cortisol 
concentrations in three female dogs varied from 78.34 to 179.39 ppb, with a mean value 
of 120.94 ppb (SD = 29.58). Cortisol concentrations in two male dogs varied from 
46.32 to 109.96 ppb, a mean value is 65.52 ppb (SD = 20.2). The possible causes of 
variability are (1) breed; (2) variability in the adrenal response to excitement. 
A T test was carried out to determine if the basic mean cortisol concentrations are 
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Figure 9. Day to day variation curves of cortisol level of five dogs by TDx 
FLx, error bars indicating 2 SD, n =3 
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influenced by gender. The results indicate that the average cortisol level of female dogs is 
significantly higher than that of the male dogs {P= 0.002). In literature, only one report 
indicated that basal female serum cortisol levels were significantly higher than levels in 
male normal dogs (Garnier et al., 1990). Their explanation for this phenomenon was that 
males and females have different ability to become acclimatized to their housing 
condition. The acclimatization appeared to occur faster in males than in females. 
Figure 10 represents the univariate scattergrams of cortisol levels of 20 blank 
urine samples from five research dogs, with error bar indicating 2 SD. 
Administration urine 
FPIA analysis of administration urine from two dogs # 9485 female and # 9491 
male, each dog received an intravenous injection of 50 mg hydrocortisone sodium 
succinate. Urine samples were collected immediately before injection of cortisol and 2, 4 , 
6, 8, 12, 24, 26, 48, 72, 96, 120, 140, 164, and 196 hours after administration. Cortisol 
levels were determined in triplicate. Standards and controls were analyzed in duplicate. 
Both dogs reached maximum excretion of cortisol in the urine at 2 hours post 
administration. In both dogs , the farthest time point post dose at which cortisol levels are 
not significantly different with that of at 0 hour pre dose, defined by T test, is 12 hours 
post dose (P=0.45 dog #9485, P=0.07 dog #9491). At 24 hours post dose, dosed 
cortisol levels of two dogs are also not significantly different with normal cortisol levels 
(P=0.35 dog #9485, P=0.05 dog #9491) . Table 6a and 6b represents the T test data. 
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Figure 10. Univariate scattergrams of cortisol concentrations of 20 urine samples 
from five research dogs, error bar indicating 2 SD 
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Table 6a. Data from T test (12 hours post dose) 
Unpa ir ed l - Tesl X 1 : Column 1 Y 1 : Co l umn 2 
Prob . (2-tai l ) : DF : Unpaired t Va lue : 
1.4514 1.797 
Group · Count · Mean Std Dev · Std . Error : 
Element 1 4 16 .445 2 .357 1 .179 
Element 2 5 14 .252 5 .024 2 .247 
Unpai r ed l-Tesl X 1 : Co l umn 1 Y 1 : Column 2 
Prob . (2-tail) : Unpaired t Value: 
l -2 .02 1.0741 
G rouo : c t oun M ean : Std D ev .: Std E rror : 
Element 1 4 8 .342 3 155 1.577 
Element 2 7 12 .911 3 .814 1.442 
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Table 6b. Data from T test (24 hours post dose) 
Unpaired t-Test X 1 : compar e groups Y : cortisol in tensity units 
Prob . (2-lail) DF . Unpaired l Value 
1 3523 1.996 
Grouo . c ount M ean : Sld D ev . · Sld E rror 
control 4 16 447 2 358 1. 179 
dosed 5 13 63 5 187 2 .32 
Unpaired l-Test X 1 : comp ared groups Y : cor ti sol intens i ty units 
DF : Unpaired t Value Prob . (2-ta i l ) 
1-2 .272 1.0464 
G roup Count Mean . Std. Dev : Std . Error . 
control 4 8 342 3 155 1 577 
dosed 8 12.268 2 665 .942 
148 
The results indicate that endogenous urinary cortisol levels can not be significantly 
distinguished from dosed urinary cortisol levels for 12 or 24 hours post dose. These 
statistical date provides very important information about cortisol urinary clearance 
kinetic in dogs , and it also helps us to identify the post dose time point regarding the 
differentiation between endogenous cortisol urinary levels and dosed urinary cortisol 
levels. Absence of these information can lead to cortisol values in dogs which would be 
incorrect or have doubtful significant in correlation with normal cortisol population 
determination and endogenous/exogenous cortisol levels differentiation. 
The urinary excretion profiles of cortisol in two greyhounds after i. v 
administration are showed in Figure 11 and 12. Figure 13 shows portions of urinary 
excretion profiles (post dose 24 hours) from dog # 9485 and # 9491. The whole urinary 
excretion profiles of dog # 9485 before and after cortisol administration are showed in 
Figure 14. The mean concentration of cortisol of seven samples from dog # 9485 pre and 
post 24 hours administrated urine samples was 125.88 ppb (SD=27.52). 
Figure 15 shows the comparative study between normal corti sol levels of research 
dogs and dosed cortisol levels for 196 hours post hours of dog #9485 and #9491 at 
therapeutic use level (50 mg hydrocortisone sodium succinate per dog i. v). From the 
figure, it can be clearly seen that at 12 hours or 24 hours post dose time, all dosed 
cortisol levels of both dogs are within the 2 SD range of normal cortisol levels. At 8 
hours post dose, only dosed cortisol levels of dog #9485 are within the 2 SD range of 
normal levels, 8 hours post dosed level of dog #9491 is outside of the 2 SD range of 
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Figure 11 . Urinary profile of dog #9485 following administration of 50 mg 
cortisol iv. by TDx FLx , error bars indicating 2 SD, n = 3 
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Figure 12. Urinary profile of dog #9491 following administration of 50 mg 
cortisol iv. by TDx FLx, error bars indicating 2 SD, n=3 
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normal cortisol levels. At 6 hours post dose, dosed cortisol levels of both dogs are 
outside of the 2 SD range of normal cortisol levels. 
From the results presented above, we are able to conclude that normal cortisol 
levels can not be easily distinguished from dosed cortisol levels for 12 hours or 24 hours 
post dose, which consistent with the results of T test. The finding seems to indicate that 8 
post dose hours is the time point at which normal cortisol levels can be statistically 
distinguished from dosed cortisol levels. For accurate determination of this crucial time 
point, more samples from administrated dogs will be needed . 
The normal concentration of cortisol in track do1: urine 
102 track dog urine samples were chosen for this study. These samples have been 
monitored by TLC for cortisol presence prior to FPIA analysis to eliminate the influence 
of cortisol or corticosteroid treatment. Within TLC detection range, all of the samples 
turned out to be negative. 
Calibration standards, consisting of cortisol (250, 100, 50, 25 , and 10 ppb), were 
analyzed in duplicate with each batch of samples. Two or three control samples were 
included with each batch of samples. The mean concentration of cortisol of 96 track dog 
urine samples was 115.1 ppb (SD= 99.4) but covered a wide range from 10.1 to 343.0 
ppb. Unreliable low response (below detection limit, not significantly different with 0 
ppb) from five dogs were not included. Data from one sample (784. l ppb) which is out 
of the 3 SD range was also not included. 
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In the literature, Irvine et al. (1988) measured the amounts of free cortisol in 
routine post-race urine samples from 110 horses and investigated causes of variability. 
They concluded that possible causes of the variability were: (1) Breeds; (2) Variability in 
the adrenal response to excitement and exercise; (3) The effects of vasopressin 
(antidiuretic hormone) which showed a marked but variable increase during a stimulated 
raceday. Other studies also indicated that the large variation in the quantities of 
corticosteroids secreted by different dogs under uniform experimental conditions are 
possible (Hechter et al., 1955). 
Figure 16 shows the univariate scattergrams of cortisol levels of 96 track dogs, 
with error bar indicating 2 SD. Figure 17 represents the comparative study between 
normal cortisol levels of track dogs and dosed corti sol levels for 196 hours post dose of 
dog #9485 and #9491. The results are consistent with the finding from comparative study 
between normal cortisol levels of research dogs and dosed cortisol levels of same two 
dogs. A T test has been done to determine if there is significant difference between 
normal cortisol levels of research dogs and normal cortisol levels of track dogs. The 
results indicate that statistically there is no difference between two groups (P =0.56). 
Data from T test are given in table 7. 
Practicability 
FPIA assay is a very simple, fairly sensitive, reproducible and time saving method 
for cortisol analysis. Cross-reactivity studies also show it to be adequately 
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Figure 16. Univariate scattergrams of normal cortisol concentrations of 96 track 
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Table 7. Data from T test (Research samples and track samples) 
Unpaired l-Tesl X 1 : Column 8 Y 1 : concentrations ppb 
Prob. (2-lail ): DF: Unpaired l Value : 
1.5556 I 114 1 59 1 
Gr oup · Count · Mean Sld Dev . Sld Error 
lr ack dogs 96 115 118 99 401 10. 145 
rese dogs 20 101 753 37 .05 1 8 285 
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specific for the quantitative measurement of cortisol. It does not need prior extraction and 
cleanup procedure. However, immunoassay in general are often considered a method with 
poor specificity because the antiserum used may cross react with other structurally similar 
compounds and as such absolute values for a single analyte cannot be assured. 
In most racing chemistry laboratories, a reliable confirmation method such as 
GC/MS or HPLC are usually recommended to validate the use of FPIA and to assure the 
identity of analyte resulting in the endogenous concentrations observed. Regarding 
cortisol assays, the HPLC methods offer the advantage of a sufficient specificity. High 
resolution capillary GC/MS remains the method of choice for the final confirmation of 
cortisol in complex biological extracts with proper derivatization. Further comparisons 
between TDx assay and classical methods should be included in future study. 
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SUMMARY 
This study investigated the characteristics of analytical method such as detection 
limit, specificity, reliability, precision and accuracy, and determined endogenous 
population level of cortisol in the greyhound urine using the optimal method of choice. 
Gas chromatography/mass spectrometry is regarded as one of the confirmation 
method for cortisol analysis, but prior derivatization of cortisol is usually necessary 
before injection to GC/MS system because cortisol is not a thermal stable compound , 
which makes the analysis procedure more complex and difficult. 
Through literature review, it is noticeable that high performance liquid 
chromatography is commonly used for cortisol analysis. It is reported that HPLC can 
detect cortisol levels in the low nanogram range (Schoneshofer et al., 1980; Park et al. , 
1990; Wade and Haegele. , 1991). However, prior sample preparation and extraction 
procedures are usually time consuming, and the method requires large sample volumes. 
Among the classical analytical methods investigated, Thin layer chromatography 
usually be used as initial screening method but not suitable fo r confi rmation and 
quantitation . 
Newly developed immunochemica1 assay FPIA offers the advantages that it is 
relatively easy to perform, can be performed rapidly, without the need for sample 
preparation , and has a fair degree of sensitivity, precision and specifi city for overall 
confirmation of cortisol in biological samples. 
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The results generated by the FPIA assay for the screening and confirmation of 
cortisol in urine indicated that the assay had good intra and inter-assay reproducibility 
with a fair degree of sensitivity and specificity. The lowest detection limit was 10 ppb in 
urine. Diurnal variation of cortisol in dog was also included in this study, results showed 
that cortisol levels in dog urine might be subject to diurnal variations. In two female 
dogs, cortisol urinary levels were the highest in the morning hours and lowest in the 
afternoon. In one male dog, cortisol levels did not change significantly throughout 24 
hours . A T test was carried out to determine if the cortisol levels were influenced by 
gender, the results indicated that the average cortisol level in female dogs was 
significantly higher than that of the male dogs. For accurate determination of diurnal 
variations and gender difference, more urine samples and statistical analysis are 
necessary. For threshold level determination, the FPIA assay detected presence of cortisol 
in all of the normal blank urine samples analyzed. The normal concentration of cortisol in 
research greyhound urine is 101.8 ppb (SD= 37. 1). The normal concentration of cortisol 
in track greyhound urine is 115. 1 ppb (SD= 99.4) . 
In terms of distinguishing between endogenous cortisol levels and exogenous 
cortisol levels, FPIA assay is able to detect the presence of corti sol in all of the blank 
urine samples and dosed urine samples analyzed. At 50 mg cortisol per dog dosage, 
endogenous urinary cortisol levels are not significantly different with exogenous urinary 
levels for 12 or 24 hours post dose. 
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SUGGESTIONS FOR FUTURE WORK 
Future work could include further investigating and comparing extraction and 
sample preparation techniques to DMSO and its metabolites such as protein precipitation 
techniques. It would be of interest to know which of the various sample preparation 
techniques gives better spike recovery and clear solution results. More administration 
study of DMSO and DMS02 in dog and statistical analysis are also necessary regarding 
the differentiation between endogenous levels and dosed levels of these two drugs . 
In terms of cortisol analysis, future work should include comparison study of the 
quantitation of urinary free cortisol using FPIA assay and gas chromatography /mass 
spectrometry with proper derivatization. It could then be determined if there is good 
correlation between the absolute values of free cortisol obtained by FPIA assay and the 
values obtained by GC/MS. 
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APPENDIX 
TDxFLx Fluorescence Polarization Immunoassay 
Materials Supplied in Kit 
TDx/TDxFLx Cortisol Reagent Pack: 
P Cortisol pretreatment solution. 
Surfactant in buffer ( 4 ml). 
Preservative: 0.1 % sodium azide. 
S < 1 % cortisol antiserum (mouse, monoclonal and goat) solution. Stabilizers in 
buffer (3 ml) . 
Preservative: 0 . 1 % sodium azide. 
T < 0.01 % cortisol fluorescein tracer solution. 
Surfactant and stabilizers in buffer (3 ml). 
Preservative: 0.1 % sodium azide. 
Cortisol calibrators: 
Six vials with accurately measured amounts of corti sol in buffer at the following 
concentrations: 
Vial Cortisol concentration (µg/dl) 
A 0.0 
B 2.5 
c 5.0 
D 
E 
F 
10.0 
25.0 
60.0 
Preservative: 0 .1 % Sodium azide. 
Cortisol Controls: 
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Vial Cortisol Concentration (µg/dl) 
L 2.6-5.4 
.rv1" 12.2-17.8 
H 33.2-46.8 
Preservative: 0.1 % sodium azide. 
Reaeents not supplied in kit: 
Hydrocortisone standard at l µglml (methanol) 
Blank urine sample. 
Procedure 
1. Prior to performing the assay, allow all reagents to reach room temperature. 
2. Vortex samples for 5 seconds prior to use. 
3. Perform instrument calibration using cortisol calibrators. 
4. Add 75 µl of standard, or control/sample to tri-well cartridges on carousel. 
5. Put reagent pack into the analyzer. 
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6. Start run. 
7. Get print out of fluorescence intensity of each sample 
